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Abstract 
Background 
Childhood hypertension is of great concern parallel to the obesity epidemic and early 
manifestation of antecedents of primary hypertension like arteriosclerosis.  Patterns of early 
growth are associated with spiraling rates of raised blood pressure (BP) in paediatric populations. 
However, not much is known about early growth and its effect on BP from childhood to early 
adulthood.  This study hypothesizes early life growth is associated with BP from childhood to 
adulthood. 
Methods 
Data for this study came from a sample of black children from the Birth to Twenty cohort study 
of children born in Soweto, Johannesburg in 1990. Firstly, persistence of elevated BP between 
ages 5 and 18 was estimated from sex, anthropometry and BP measurements. Secondly, the 
association between socio-economic status (SES) change between infancy and adolescence 
computed from physical household assets and BP at 18 years of age was evaluated using 
multivariable analyses. Finally, longitudinal BP trajectories were identified using group-based 
trajectory modeling and multinomial models were used to assess the association of BW, RWG 
and RHG, and BP trajectories adjusted for several covariates.  
Results 
The prevalence of hypertension ranged between 8.4 to 24.4% and  risk of maintaining the 
elevated BP status was almost 2-fold between ages 5 and 18 years: RRR: 1.60(95%CI: 1.29-
xix 
 
2.00). An upward social mobility was associated with a 5mmHg reduction in SBP (β: -4.85, 
95%CI: - 8.22 - -1.48).  Three distinct early patterns of BP development called trajectory groups 
were identified for SBP and diastolic BP (DBP) for each sex; namely: “lower”, “middle” and 
“upper.” A kilogram increase in birth weight (BW) reduced the odds of being in the middle 
compared to lower SBP trajectory (OR: 0.75, 95%CI: 0.58-0.96), while RWG in infancy was 
associated with a 4-fold increased odds of being in the upper vs lower SBP trajectory for boys 
(OR: 4.11, 95%CI: 1.25-13.51).  In girls, relative weight gain (RWG) (OR: 1.63, 95%CI: 1.08-
2.46; 1.77(1.22-2.56)) and relative height gain (RHG) (OR: 1.90, 95%CI: 1.27-2.86; 2.12(1.39-
3.23)) in infancy and mid-childhood was associated with almost 2-fold increase in odds of being 
in the upper vs lower trajectory. The middle SBP trajectory in girls was predicted by RWG (OR: 
1.33, 95%CI: 1.00-1.76) and RHG (OR: 1.58, 95%CI: 1.15-2.17) in infancy.  DBP trajectories 
were significantly but inconsistently associated with RWG and RHG for boys and RWG in mid-
childhood and infancy in girls for the middle and upper trajectories.  
Conclusions 
Distinct BP trajectories are established in childhood and persist into early adulthood. Improving 
SES throughout childhood may have a protective effect on BP.  Policy recommendations around 
early identification of children with elevated BP accompanied by interventions targeted at 
optimal growth and interrupting the atypical BP trajectories may reduce the burden of disease 
attributed to hypertension, especially in girls.  
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Preface 
 
"As obesity creeps into preschools, and hypertension and type II diabetes become pediatric 
problems for the very first time, the case for starting preventive health care in the cradle has 
become too compelling to keep ignoring." 
Author: Heidi Murkoff 
 
 
After an outstanding postgraduate experience as a Masters Student and research assistant in Birth 
to Twenty, I was very excited about the opportunity to continue my career in research through 
doctoral studies.  This interest was prompted by the experience I had gained in data collection on 
anthropometry and blood pressure in the Birth to Twenty Cohort Study where I noted that there 
were some participants who had high blood pressure and were to be sent to the Research nurse 
for referrals to seek medical attention.   
 
My professor and mentor, Shane Norris, simultaneously ignited my interest in blood pressure 
studies in the black South African population and challenged my quest and my capabilities into a 
higher level of critical thinking and encouraged me to knit my ideas into a researchable 
hypothesis: “blood pressure tracks in distinct manner throughout childhood and is influenced by 
early life growth and socioeconomic status change from birth.” 
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To explore this argument, I conducted an extensive literature review and worked on protocol 
development, ethics clearance, data collection, cleaning and analyses, dissemination of results 
though peer-reviewed scientific publications and media pieces. This thesis is constructed through 
a publication route comprising three academic papers.  
 
The outline of the thesis is illustrated below and consists of three sections: the general 
introduction, empirical chapters and general discussion.  The introduction section sets the scene 
for the thesis which includes the background of the study comprising the problem statement and 
conceptual framework, literature review and abbreviated methods.  Then, the second section 
includes chapter 3 which lays a foundation by characterising blood pressure profiles of children 
in this cohort followed by chapter 4 exploring the social determinants of blood pressure in young 
adulthood then chapter 5 concludes the empirical section by presenting the relationship between 
early growth and life course blood pressure trajectories from childhood to adulthood.   
 
The thesis is concluded with a general discussion evaluating the extent to which the study 
addressed the hypotheses, validating the conceptual framework and a reflection on the emerging 
themes. It also evaluates study limitations, relevance and implications of these findings and 
future work.  
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PART 1:  GENERAL INTRODUCTION  
 
• Chapter 1:  Background of the study and  Literature review 
 
 
• Chapter 2:  Methodology 
 
PART 2:  EMPIRICAL CHAPTERS 
 
• Chapter 3:  Blood pressure tracking in urban black south african children: birth to twenty 
cohort (published) 
 
 
• Chapter 4:  Association of socioeconomic status change between infancy and adolescence 
and blood pressure in South African young adults: Birth to Twenty Cohort (published) 
 
 
• Chapter 5:  Early life weight gain and life course blood pressure trajectories: Birth to 
Twenty Cohort (published) 
 
PART 3:  GENERAL DISCUSSION 
 
• Chapter 6: Discussion and Conclusion 
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PART 1: GENERAL INTRODUCTION 
 
 
 
 
Children are our greatest treasure. 
They are our future - Nelson Mandela 
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1 CHAPTER 1: INTRODUCTION 
1.1 BACKGROUND 
High blood pressure (BP) in children and adolescents is increasingly becoming a major health 
concern, especially in the face of the rising obesity epidemic over the recent decades (1).  
Childhood BP could be a window to adult hypertension since BP tends to track from childhood 
to adulthood (2).  Identifying key childhood factors that influence blood pressure may be crucial 
for early life intervention to reduce the burden of disease attributed to hypertension in adulthood. 
 
South Africa is going through a rapid nutrition and epidemiological transition as a result of 
socioeconomic changes and rapid urbanisation in the post-apartheid era.  This is accompanied by 
a rising burden of non-communicable diseases in the midst of communicable diseases like 
HIV/AIDs, as well as a double burden of malnutrition. Children have also been caught up in this 
transition, with the co-existence of under-nutrition and over-nutrition, often in one household, 
leading to growth faltering (3, 4).  
 
An emerging body of evidence has reported that an adverse early life environment influencing 
growth is related to high BP in childhood and adulthood.  Specifically, children who are born 
small but gain more weight in early postnatal life are at higher risk of having raised BP in later 
life (5).  Little is known about the impact of early life growth on longitudinal patterns of blood 
pressure over time, especially in South Africa where there is paucity of longitudinal data. 
3 
 
Therefore, this study seeks to assess longitudinal blood pressure profiles in urban South African 
children and examine their relationship with early life growth and socioeconomic status. 
 
1.1.1  Extent of the problem under study 
Hypertension remains a major global health threat and a modifiable risk factor for cardiovascular 
diseases (CVDs), strokes, dementia, renal failure, premature death and disability (6).  By 2013, 
hypertension ranked the most expensive risk factor for disease burden across the globe with an 
estimated cost of all diseases attributed to hypertension at 208.1 million disability-adjusted life-
years (DALYs), and raised blood pressure being responsible for 10.4 million deaths mainly due 
to cardiovascular diseases represented by a light blue colour in Figure 1-1(7) . 
 
Almost a billion people worldwide are affected by hypertension with a disproportionate number 
of these residing in low-middle income countries (LMICs), and the under-privileged are more 
affected even in high income countries. (8).  There is evidence suggesting that hypertension in 
adulthood may have its origins in childhood (9, 10).  Several early life factors including 
socioeconomic status (SES) and growth are associated with raised BP (11). Paediatric 
hypertension is an emerging major health issue worldwide which is increasing in parallel to the 
rising obesity epidemic which is an established risk factor for elevated BP in children and 
adolescents (12). 
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Figure 1-1 Main risk factors contributing to the Global burden of disease (% global DALYs) in 
2010 (13) 
 
Global estimates for hypertension in children and adolescents are not as well documented as in 
adults because of lack of regional statistics and the blood pressure measurement is often 
overlooked in paediatric practice. However, emerging evidence has shown that it is no longer a 
rare phenomenon as previously believed (14-16).  Primary hypertension is defined as 
key 
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hypertension with no obvious origin, while secondary hypertension can be as a result of an 
underlying health problem like renal or cardiovascular disease (17). Primary or essential 
hypertension is now being diagnosed in children and adolescents.  
 
According to a recent review of global estimates of hypertension one in four adolescents in 
Africa is hypertensive (18). Children with elevated BP are at higher CVD risk compared to their 
normotensive counterparts and manifest physiological indicators of preclinical target organ 
damage, heart disease and renal failure  including carotid intima media thickness (19), 
atherosclerosis, left ventricular hypertrophy (20), and micro albuminuria (21). 
 
1.1.2 Study context:  South Africa in transition  
Urbanisation and recent socio-economic changes in South Africa since the end of apartheid in 
1990 have fuelled a rapid nutritional transition and an epidemiological shift especially in the 
urban black population (22). The nutrition transition is characterised by a rapid shift towards 
high fat and sugar consumption, refined foods, acculturation and increased physical inactivity.  
This is accompanied by a dramatic shift in the burden of disease from communicable disease to 
non-communicable diseases including coronary heart disease and stroke for which high blood 
pressure is a key risk factor (23). 
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As of 2000, approximately 47 000 deaths occurring in South Africa were attributable to high 
blood pressure, a leading cause of death together with sexually transmitted disease (STDs) (24). 
South Africa still faces a multifaceted burden of disease; from the HIV pandemic to nutrition 
related non communicable diseases including hypertension and diabetes (25). 
 
 
Figure 1-2 Deaths attributable to hypertension in South Africa , 2000 (24) 
 
Children living in South Africa have been caught up in this rapid transition as evidenced by the 
rising prevalence of overweight and obesity, physical inactivity, high fat and salt diets and 
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refined foods (26).  This is characterised by the co-existence of over-nutrition and under-
nutrition, especially among the black population who make up the majority of the South African 
population. The rising trends of overweight and obesity in children as young as 2-5 years of age 
is of particular concern.  According to the South African National Health Survey completed in 
1998,  the prevalence of obesity among children aged between 2 and 5 years was 20.5%, despite 
high levels of stunting in this age group (21.6%) (27).  
 
1.1.3 Conceptual framework for life course approach to hypertension and other chronic 
disease risk 
The aetiology of primary hypertension is complex and often multi-factorial with increasing 
evidence supporting the notion that even though hypertension is partly genetic in origin, the 
recent rapid progression and degree of variation in hypertension cannot be fully explained by 
genetics (28).  Barker and colleagues proposed that adverse early life environment  interacting 
with genes, even before birth, may set a series of physiological and metabolic changes which 
might change the life course ‘trajectory’ of an individual’s health (29). There is need to 
understand  the importance of early life factors  in setting BP patterns in a growing child using 
the life course approach. 
 
The WHO conceptual framework on the life course approach to the aetiology and prevention of 
chronic diseases in figure 1-3 illustrates how biological, behavioural, psychosocial conditions, 
nutrition status, and rapid or restricted growth across the life course as well as across 
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generations, affects the onset and progression of chronic conditions like hypertension (HT) 
independently, cumulatively or interactively.  It states that an individual `s health trajectory is 
influenced by a number of societal and environmental exposures across the life span which 
includes foetal and  infancy, childhood, adolescence, adulthood and ageing (30).  
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Figure 1-3 The WHO life course approach conceptual framework for prevention of non-communicable diseases (30)
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The conceptual framework incorporates critical periods and the accumulation models postulated 
by Ben-Shlomo and Kuh (31)  The critical period model suggests that any environmental (either 
biological or social) insult during critical periods of growth and development has an adverse 
long-lasting effect on later disease risk with or without modifying factors.  This is based on the 
developmental origins of health and diseases hypothesis (DOHaD) which states that if the 
environmental cues coincide with the critical period of development when individuals are at high 
level of plasticity, they can influence short and long term adverse health outcomes like 
hypertension (29). The accumulation model states that exposures which are related to chronic 
disease risk accumulate over an individual’s life span or across generations with independent 
insults or with a clustering of risk (32). 
 
The conceptual framework is applicable to this current study, primarily because it realises that 
risk factors for chronic diseases are established earlier in life and continue over the entire life 
course.  For instance, blood pressure profiles from birth track into adulthood and across 
generations predisposing individuals at any stage of life to cardiovascular disease risk and 
hypertension. In support of this, studies have shown that BP in early life predicts cardiovascular 
risk in later life, independent of current BP (33).  
 
The framework also states that rapid growth resulting from over-nutrition is linked to 
hypertension development. This supports the evidence that adverse early life factors (social or 
biological) or across generations, resulting in foetal intrauterine growth restriction (IUGR) and/or 
11 
 
premature delivery followed by rapid postnatal growth is linked to high BP in later stages of life 
(34).  Conversely, it also states that under-nutrition leading to retarded growth followed by over-
nutrition and rapid growth leads to elevated BP. It also recognises the existence of over-and 
under-nutrition in populations in transition like South Africa, which when coupled with rapid and 
retarded growth in early life will both lead to the development of chronic diseases like 
hypertension, obesity and diabetes.  
 
The framework also highlights that societal and environmental factors shape the life course 
trajectories across the life span. Socio economic transition due to industrialisation has exposed 
populations to deleterious infant feeding practises, dietary and physical activity patterns and a 
disproportionate increase in NCDs putting more pressure on the health care system.  Though 
social gradients in BP may be different between HICs and LMICs, there is evidence reporting 
that low SES is related to high prevalence of hypertension in childhood and adults (35).  For the 
purposes of this study, I focussed only on the early life portion of the framework which 
encompasses early rapid growth during foetal, infant period, early childhood and late 
adolescence and blood pressure between ages 5 and 18 years 
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1.2  LITERATURE REVIEW 
This literature review includes hypertension epidemiology: definition, physiology, assessment, 
definition, prevalence and the biology of hypertension in a growing child. It also comprises 
evaluation of evidence on the association between socioeconomic status during the life course 
and blood pressure, and longitudinal BP patterns, their predictors and methodological 
considerations.  
 
1.2.1 Definition and pathophysiology of raised blood pressure  
Blood pressure is defined as the force exerted by circulating blood against the walls of blood 
vessels.  It is jointly determined by the amount of blood ejected into the circulation system by the 
heart (cardiac output) and the force of the circulation system that impedes blood flow (total 
peripheral resistance), and an increase in either will result in an increase in blood pressure (36).  
                                         
 
 
Figure 1-4 Definition of BP (36) 
Blood pressure 
(ARTERIES) 
Total peripheral 
resistance 
(ARTERIOLES) 
Cardiac output (CO)      X 
(HEART)             
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1.2.1.1 Physiological control of blood pressure  
The pathophysiology of primary hypertension in children and adolescents is not fully understood 
because it arises from interaction of a number of complex physiological processes related to the 
interaction of genetic and environmental factors. Some of the physiological factors linked to 
elevated blood pressure (increase cardiac output and/or total peripheral resistance) are over-
activation of the sympathetic nervous system (37), obesity and insulin resistance (38), stress (39), 
reduced nephron number, renal salt retention  accompanied by increased fluid volume and 
preload, especially in black populations(40), excess renin-angiotensin, structural and functional 
changes on the arterioles, and endothelial dysfunction (41).  
 
 
Figure 1-5 Factors involved in BP control (42)  
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Based on the equation defining BP illustrated in Figure 1-4 and 1-5, an increase in cardiac output 
is caused by an increase in heart rate and/or stroke volume. Stroke (fluid) volume is the amount 
of blood ejected from the heart with each contraction. Increased fluid volume may be a result of 
renal sodium retention due to impaired renal function in filtration, low nephron number or excess 
dietary sodium intake. Increased heart rate or contractility is mainly induced by over activity of 
the sympathetic nervous system (SNS). Prolonged stress induced contraction of blood vessels 
may result in hypertrophy leading to increased CO and TPR, and elevated BP (43).    
  
On the other hand, total peripheral resistance is influenced by levels of functional 
vasoconstriction in small arterioles and structural changes in the peripheral arteriolar walls 
resulting in thickening of the blood vessel walls (structural hypertrophy). These changes may be 
caused by endothelial dysfunction, obesity-induced hyper-insulinemia, epigenetic effects on cell 
membrane transport function, or interaction between the SNS and the renin-angiotensin system. 
Increased secretion of renin from the kidneys may be triggered by stimulation of the SNS 
resulting in increased peripheral vascular resistance. 
 
1.2.1.2 Blood pressure assessment  
Over the years, a mercury sphygmanometer has been used to indirectly measure changes in 
arterial pressure throughout a cardiac cycle.  Blood pressure is read as millimetres of mercury 
(mmHg) recorded as a fraction: systolic over diastolic pressure.  Pulse pressure is the difference 
between the systolic and diastolic pressures and normally ranges between 30-50mmHg in adults.  
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Mean arterial blood pressure is the average pressure driving blood forward into the tissues 
throughout the cardiac cycle. Because it is closer to the diastolic pressure since two thirds of the 
cardiac cycle is spent in the resting state, the mean arterial pressure is calculated as follows: 
diastolic BP + 1/3 pulse pressure. For example: at 120/80mmHg, mean arterial pressure = 80 + 
1/3(40) =93mmHg. 
 
1.2.1.3 Blood pressure classification in children and adolescents 
Blood pressure classification and definition of hypertension in children and adolescents are of 
increasing concern in the light of the importance of early life BP in the etiology of adult high 
blood pressure and cardiovascular diseases. However, its definition is complex and not fully 
understood with many methods being explored in a bid to characterize hypertension in 
childhood. Traditionally, before the 1970s, the cut-off for hypertension in children was classified 
as 140/90mmHg, similar to adults, leading to under-diagnosis of primary hypertension (44).  
  
In 1977, a task force on blood pressure in children and adolescents prepared a first report on BP 
in paediatric populations and classified hypertension according to age and sex using a large 
nationally representative sample (45).  Over the following decade, the first report was re-visited 
incorporating height into the age-sex-specific BP percentiles leading to the 1996 updated report 
on BP definition in children and adolescents (46).  In 2004, the 4
th
 report on high blood pressure 
in children and adolescents by the National High BP Education Program (NHBPEP) presented 
classifications of age, sex and height specific BP percentiles which were defined as the systolic 
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and/or diastolic blood pressure above 95
th
 percentile for age, sex and height based on at least 
three measurements in Table 1-1(47).   
 
The NHBPEP’s age, sex and height specific percentiles have been widely used in different 
settings beyond the USA bringing a new era in understanding the epidemiology of paediatric 
hypertension. However, running these algorithmic BP classifications is cumbersome and 
interpretation of the percentiles is time consuming and makes it difficult to incorporate into 
routine paediatric practice or for use by caregivers and parents. 
 
Table 1-1 Classification of hypertension risk in children and adolescents <18 years of 
age according to age, height and sex percentiles (47) 
Category  Systolic pressure/ Diastolic pressure (percentiles) 
Normal  <90
th
  
Pre-hypertension  ≥90th   to <95th  or SBP>120 mmHg and/or 
DBP>80mmHg 
Stage 1 hypertension ≥95th   to <99th  
Stage 2 hypertension ≥99th  
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Recently, simplified tables condensed from the NHBPEP percentiles have been proposed (48). 
Kaelber and Pickett proposed a simplified tool for BP screening in children aged 3-18 years. 
They defined the abnormal BP range  as (>90
th
 percentile) for age and gender for the lower limit 
height that is the 5
th
 percentile or 120/80mmHg for pre-hypertension , even if the BP is less than 
the 90
th
 percentile for age and gender (Table 1-2)(48).  
 
Table 1-2  BP values representation the minimum of abnormal BP based on age, sex 
and minimum height percentiles 
Age, y Blood pressure , mmHg 
 Male Female 
 Systolic Diastolic Systolic Diastolic  
     
3 100 59 100 61 
4 102 62 101 64 
5 104 65 103 66 
6 105 68 104 68 
7 106 70 106 69 
8 107 71 108 71 
9 109 72 110 72 
10 111 73 112 73 
11 113 74 114 74 
12 115 74 116 75 
13 117 75 117 76 
14 120 75 119 77 
15 120 76 120 78 
16 120 78 120 78 
15 120 80 120 78 
≥18 120 80 120 80 
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The second simplified method adopted from the NHBPEP by Mitchelle et al, plotted the 
minimum for the 95
th
 percentile for children aged between 3 and 17, regardless of sex or height, 
for both SBP and DBP, separately (Table 1-3)(49). 
 
Table 1-3 A simplified BP table for hypertension screening in children and adolescents  
Source (49) 
Look up blood pressure  
Age in years Systolic BP (mmHg) Diastolic BP(mmHg) 
3 to <6 ≥100 ˃60 
6 to <9 ≥105 >70 
9 to <12 ≥110 >75 
12 to <15 ≥115 >75 
≥15 ≥120 ≥80 
 
In 2011, another definition for paediatric hypertension was introduced using BP to height ratios 
(BPHR), that is: SBPHR/DBPHR of 0.75/0.48 and 0.78/0.51 for boys and girls, respectively. 
This method was postulated by Lu and colleagues using data from China on adolescents (50).  It 
is a very simplified, inexpensive method that has been tested for consistency with the NHBPEP 
and has been replicated in diverse settings including Africa (51-53). Nonetheless, its major 
limitation is failure to account for the age of the child since BP increases with age hence many 
studies have used NHBPEP as a definition of choice. 
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1.2.2  Epidemiology of hypertension in children and adolescents 
This section describes the prevalence of hypertension and the factors associated with primary 
hypertension in a growing child. 
 
1.2.2.1 Prevalence of paediatric hypertension 
There is growing concern about the increasing proportion of children and adolescents with 
elevated BP worldwide.  Global estimates of the prevalence of hypertension (HTN) in children 
and adolescents are not fully understood due to lack of nationally representative data from all 
regions, and methodological discrepancies with respect to its measurement and definition.  But 
over the past two decades reports have suggested that there is a dramatic increase in the 
prevalence of hypertension with several paediatric studies across the globe reporting prevalence 
of 1.0% in rural South Africa among boys aged 6-13 years (54) to 28% in Chinese children aged 
7-17 years (55) (Table 1-4).  Though these studies vary with regard to study design, 
methodology and setting, they give a clear picture that paediatric hypertension is an emerging 
problem, especially in the context of rising obesity levels and other health-related behaviours in 
this population. 
 
All of the prevalence studies found in the literature search were cross sectional by design, 
conducted mainly in school settings, raising questions about the potential to establish causality 
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and generalizability of findings across populations. Furthermore, there is a paucity of data from 
urban South Africa where the nutrition transition is more evident compared to rural settings. 
   
It is noteworthy that most of the studies done outside South Africa had three visits and three 
measurements on each occasion, and as a result the prevalence of hypertension was lowest at the 
3
rd
 visit. The proportion of the hypertensive children in the studies that had multiple visits 
decreased with each subsequent visit. This might be due to regression towards the mean or 
children getting familiar with the BP assessment procedure (56).  For instance, a study conducted 
in Uganda of children aged 7-18years reported a prevalence of hypertension of 17.1%, 7,1% and 
3.8% on the first, second and third visit on the same sample, respectively (57). Similarly, 
McNiece et al reported a prevalence of hypertension of 3,2% in the final visit in  America 
children aged 11-17 years of age (58).  Another possible reason is that childhood BP 
measurements are prone to the white coat effect attributed to stress response to a health 
measurement environment which makes it difficult to distinguish between a physiological and 
pathological BP value in paediatric populations. This raises the importance of ambulatory BP 
monitoring in children to confirm white coat and masked hypertension. However, a number of 
studies have shown that white coat hypertension is a significant predictor of CVD events related 
to target organ damage (59).  Sex differences with regards to the prevalence of hypertension 
were also noted in some studies; with two African studies reporting a prevalence of HTN higher 
in boys than girls while the Iranian study found a higher prevalence in girls than boys (51, 60, 
61).  
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The definition of hypertension and prehypertension (Pre-HTN) varies from study to study with 
most authors using the NHBPEP criteria. A few studies used their national representative age, 
height and sex specific percentiles (55, 61), while others adopted the simplified tables based on 
the NHBPEP (48, 49) or the BPHRs (50, 51, 53). A study on Nigerian children defined HTN 
based on the systolic blood pressure: height ratio over diastolic blood pressure: height ratio 
((SBPHR/DBPHR) reporting 0.75/0.51 and 0.77/0.55 for boys and girls, respectively.  
 
A variety of instruments have been used to measure paediatric BP from mercury 
sphygmomanometers to automated BP monitors like the Dinamap (58), Omrons (51, 62), 
Spacelab/Critikon(63) or  InterlliVue MP50 (64). Though many studies have used the mercury 
sphygmomanometers, it has been under scrutiny around the safety of mercury as an 
environmental pollutant and its objectivity in detecting the korotkoff- sound during measurement 
especially in children.  
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Table 1-4 Global prevalence of paediatric hypertension. 
Author(year) Location Study design  
Populatio
n  Method of measurement 
Visits(n)and 
readings 
BP definition 
/classificatio
n Prevalence (%) 
   
Age(yrs) 
   
Pre-HTN HTN 
Global 
        
McNiece et al.2007 (58) USA Cross sectional 11-17yrs Oscillometric (Dinamap) 3visit NHBPEP 15.7 3.2% 
Lu,Q.2013 (50) China Cross sectional 7-12 yrs Mercury sphygmomanometer 
3 visits 
3  
measurements 
NHBPEP 
²BPHR - 
1st :18.6% 
2nd :4.4% 
3rd: 2.7% 
Urrutia-Rojas et al. 2006 (65) USA 
       
Zhang et al. 2014(55) China Cross sectional 7-17yrs Mercury sphygmomanometer 1 visit 
Chinese 
reference - 
28%(B) 
22.5(G) 
Meng et al. (66) China        
Hakim et al. 2014 (61) Iran Cross sectional 11-12yrs Analog Barometer alpk II 
1visit 
2 measurement  ¹NTCPHBP 
SBP:11.9(B), 
7.5(G) 
DBP:14.5(B), 
12.3(G) 
SBP:18.8(B), 
28.5(G) 
DBP:15.2(B)
, 19.0(G) 
Schwiebbe et al.  2012 (67) 
Caribbean 
(Bonaire) Cross sectional 5-16 yrs Oscillometric monitor 
1visit 
2nd and 3rd 
measurement NHBPEP  
SBP:24.7% 
DBP:8.5% 
Steinthorsdottir, et al. (64) Iceland Cross sectional 9-10 yrs 
-Sphygmomanometer (2 readings) 
-InterlliVue MP50(2 readings) 
3 visits 
4 
measurements NHBPEP  3.1% 
Acosta  AA, 2012(63) USA Cross sectional  Oscillometric(Spacelab/Critikon) 
3 visits 
3 /4 
measurements NHBPEP 20% 4% 
Mitchell,C K.2011(49) USA Cross sectional 3-18 yrs Oscillometric method 
1 visit 
3 
measurements 
Simplified 
tables adopted 
from 
NHBPEP 17.2% 20.3% 
Xi, B.2014(68) China Cross sectional 8-17yrs sphygmomanometer 
1 visit 
2nd and 3rd 
measurement ²BPHR 
8-12yrs (4.7%) 
13-17yrs (14.7%) 
8-12 yrs 
(2.6%) 
13-17yrs 
(2.7%) 
         
Africa         
Kidy et al.  2014 (57) Uganda Cross sectional  7-18yrs Omron M6 
3  visits 
3 
measurements NHBPEP  
1st : 17.1% 
2nd: 7.1% 
3rd:3.8% 
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Okoh et al. 2012 (69) Nigeria Cross sectional 6-12yrs Mercury sphygmomanometer 
3 visit 
3measurements NHBPEP  4.7% 
Ellenga Mbolla et al. 2014 (70) Congo Cross sectional 5-18 yrs Auscultator method 
2 visits 
3measurements NHBPEP 
20.7% (B=16.6%; 
G=24.3%) 
1st: 10.1% 
2nd:3.3% 
Ejike CE, 2011(51) Nigeria Cross sectional 11-17 yrs Omron 
1visit 
3measurements 
²BPHR: 
SBPHR / 
DBPHR 
Only thresholds 
for ratios 
0.75/0.51(B) 
0.77/0.55(G) 
Agyemang C, 2005 (14) Ghana Cross sectional 8-16 yrs Omron M5-1 
1 visit 
2 measuremets none - - 
Odetunde et al.  2014 (71) Nigeria Cross sectional 2-5yrs Mercury sphygmomanometer 
1 visit 
3measurements NHBPEP 1.4% 0.5% 
Mehdad S et al, 2012 (72) Morocco Cross sectional 11-17 yrs Mercury sphygmomanometer 
1 visit 
2measurements NHBPEP 9.6% 17.4% 
Ng’andu NH, 1992 (60) Zambia Cross sectional 7-16yrs Mercury sphygmomanometer 
1 visit 
1 measurement 
>95th 
percentile for 
sex - 
6.9%(B) 
6.1%(G) 
South Africa         
         
Goon et al. 2012 (62) Rural Cross sectional 10-16yrs Omron 
1 visit 
2nd and 3rd 
measurement NHBPEP 
 
4.1%(B) 
2.8%(G) 
Monyeki et al. 2006(54) Rural Cross sectional 6-13yrs 
Automated Micronta 
 monitoring kit 
1 visit 
3 readings 
>95th 
percentile for 
age and sex 
 
-1.0%-
5.8%(B) 
-3.4% -
11.4%(G) 
 
Mamabolo, R.L.2011 (73) Urban Cross sectional 12-14yrs Mercury sphygmomanometer 
1 visit 
2nd and 3rd 
reading NHBPEP 
Elevated BP: 
33.1% (B); 
21.4%(G)  
Nkeh-Chungag et al. 2015 (74) Peri-urban  Cross sectional  13-17 yrs Microlife automated machine 
1 visit 
3 readings NHBPEP 
13.6%(B) 
11.7%(G) 
22.0%(B) 
20.9%(G) 
¹NTCPHBP: National Training Centre program for high blood pressure 
²BPHR Blood pressure to height ratio 
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1.2.2.2 Factors associated with blood pressure in a growing child 
Growth and development in a child is associated with morphological and structural changes in 
the vasculature and the hemodynamic tree commonly known as vascular aging. Accelerated 
growth and development is associated with high blood pressure in children and adolescents and a 
major risk factor for early vascular aging which is proxy for vascular damage and cardiovascular 
risk (74).  There is evidence to suggest that BP in childhood and adolescence is highly correlated 
with age, sex, growth and obesity, independent of other confounding factors.  For this reason 
age, sex and height are included in the classification and definition of hypertension in children 
and adolescents (47).  Other factors influencing BP in paediatric populations are ethnicity, family 
history of hypertension/genetics, bio-behavioral factors. 
 
Age 
Blood pressure gradually increases with age from childhood to adulthood but rises rapidly during 
puberty (75). Puberty has been reported to be an independent predictor of BP even in children 
who were born low birth weight (76).  Hemodynamic factors related to age-related changes in 
BP from childhood to adulthood remain unclear but could be attributed to changes in vasculature 
in a growing child as a result of structural alterations and calcification as part of vascular 
remodeling (77). Primary hypertension in childhood is associated with accelerated biological 
maturation which causes premature aging the metabolic and vascular system termed early 
vascular ageing (EVA). Key features of EVA are endothelial dysfunction, vascular remodeling, 
increased arterial stiffness and calcification which contribute to vascular injury leading to 
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increased TPR in small arteries and increased arterial stiffness thereby increasing BP (78).  There 
is evidence to show that hypertensive children compared to their normotensive counterparts have 
significantly higher bone age (79), advanced sexual maturation (earlier menarche)(80).  
 
Sex 
Sex is a major determinant of BP in a growing child hence its inclusion in the BP normotensive 
tables (81).  Sex-specific differences in age-related changes in BP have been reported to emerge 
in puberty; with some studies reporting that the rate of change of SBP being three and two times 
more in puberty compared to pre-puberty and, in boys and girls, respectively (82). Furthermore, 
studies have shown that the incidence of hypertension is higher in boys than girls (83, 84).   
 
The mechanisms underlying sex differences in age-related changes in BP and hypertension 
incidence and prevalence are not fully understood although recent reports have identified the role 
of sex differences in sensitivity to early life adverse environment and sex hormones in BP 
regulation. Furthermore, boys tend to experience more rapid ‘catch up’ growth compared to girls, 
predisposing them to higher risk of developing hypertension (85).  Ojeda et al, highlighted that 
the renin-angiotensin system may be stimulated by testosterone leading to increased BP in boys, 
especially those who experienced IUGR or adverse early life environmental insults (86). On the 
other hand, oestrogen in girls plays a protective role by inhibiting over-activation of RAS 
thereby reducing BP (87). 
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Growth  
Weight at Birth 
The fetal period is characterized by rapid cell differentiation and proliferation leaving permanent 
changes in functional organs and physiological axes, thereby increasing disease risk. This 
highlights the importance of the early life environment in the physiological programming of 
blood pressure.  Birth weight, a proxy for the prenatal environment, is inversely related to 
cardiovascular disease risk in later life (88). Low birth weight is defined as <2.5kg by the World 
Health Organization, may be a result of intrauterine growth restriction (<10
th
 percentile of birth 
weight for gestational age) or preterm birth or both (89, 90).    
 
IUGR results from fetal environmental insults including maternal factors, which influence 
structural and functional development of key organs and physiological control of BP from as 
early as conception. Prenatal insults like maternal gene-environment interactions (epigenetics) 
may program CVD risk as a result of alterations in the key structural, functional and metabolic 
processes in several organs (kidney, vasculature, brain, pancreas, liver and adipose tissue) in 
response to insults like placental insufficiency, maternal malnutrition and high levels of 
glucocorticoids leading to raised BP (91). 
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Figure 1-6 Intrauterine influences on adult chronic disease risk  
Source (91) 
 
In support of the work of Barker on the fetal origins hypothesis (92), a large body of 
epidemiological evidence has demonstrated that birth weight is inversely associated with 
hypertension  in childhood and possibly amplifies with age, even after adjusting for factors like 
smoking, current weight and SES (93).  A systematic review and meta analyses of the 
association between birth weight and SBP in childhood and adulthood reported that a kilogram 
increase in birth weight predicted a two to five mmHg reduction in SBP (34).   
 
28 
 
The mechanisms underlying the association between early life environmental cues and 
hypertension risk in childhood is not fully understood but there is evidence to suggest that IUGR 
is related to low nephron numbers (94),  endothelial dysfunction, overstimulation of the RAS and 
the SNS leading to raised BP (95). Epidemiological studies reported endothelial dysfunction 
assessed by carotid stiffness in neonates, children and young adults who experienced IUGR (96-
98).  Intrauterine growth restriction and low birth weight is related to overstimulation of the SNS 
and RAS in IUGR infants and children (99). Kingdom et al;1999,  reported stimulated cord 
blood renin activity in IUGR neonates implying that in utero insults might play a role in over-
stimulation of the RAS through stress induced activation of the SNS (100).  
 
Height 
Height is a major predictor of BP and a biologically and environmentally-sensitive trait.  Under-
nutrition leading to retarded growth in height, called stunting, is associated with raised BP (101-
103).  There is considerable evidence to suggest that children born short, who  became taller and 
gain more weight in early life are at a higher risk of having high BP.  In support of this, a study 
in Hertfordshire reported women who were short at birth but had rapid linear growth in 
childhood were at higher risk of having coronary heart disease (104). With regards to men, 
another study reported that boys who were in the highest tertile of height velocity in childhood 
had higher SBP (5mmHg), DBP (3mmHg) and a 66% increased risk of having hypertension 
compared to those in the lowest height velocity tertile (105).   
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Weight 
Evidence on the association between postnatal weight gain and BP is conflicting, some studies 
reported that weight gain in infancy is related to later BP (106, 107) while others reported no 
association (108), or both infancy and mid-childhood weight gain related to later BP (109). Early 
postnatal growth and rapid weight gain in infancy and childhood has been reported to be 
associated with risk of raised BP, especially in children who were small at birth (110). In line 
with this, most of these studies reported that high BP in individuals who had low birth weight, 
followed by rapid postnatal weight gain (5), even independent of linear growth (111).  
 
A Jamaican study reported that weight gain at one year predicted SBP in 7-11 year old children, 
while the Barry Caerphilly Growth Study found that immediate weight gain in childhood was 
associated with BP at 25 years (112, 113).  This illustrates the impact of weight accrual on BP 
which might vary with age and timing. Some reports even argue that postnatal growth might be 
more important for early onset of hypertension than prenatal growth (114).  
 
The mechanisms underlying the association between weight gain and BP are not fully 
established but research has shown that children born small but put on more weight postnatally 
tend to accumulate more fat and are at higher risk of central adiposity in childhood, a major risk 
factor for raised BP (106, 115).  Early life obesity may result from the interaction between genes 
and environment leading to hyperinsulinemia, endothelial dysfunction, activation of the renin-
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angiotensin system and the SNS which are important factors in the pathogenesis of hypertension 
(116, 117). 
 
Obesity  
Obesity is a known correlate of blood pressure across the life course (118). There is evidence to 
suggest that BMI, marker of obesity, is positively associated with high blood pressure, with the 
association being stronger for boys than girls. For instance, a  Brazilian study of children aged 
between 14-19 years of age reported that BP was associated with general and abdominal obesity 
in boys and not in girls, , despite that more girls were obese than boys (119). This could be 
attributed to the role of sex hormones and ace inhibitors in the regulation of blood pressure. 
Other factors 
Elevated BP is also related to low socioeconomic status, with children from low SES being at 
higher risk of having elevated BP compared to their wealthier counterparts (120).  Blood 
pressure in childhood is also highly correlated with family history of BP (121, 122).  In addition 
black children are at higher risk of having raised BP compared to white children and children of 
other ethnicities (123, 124).  Bio-behavioral factors like physical inactivity, alcohol intake and 
tobacco smoking have been implicated in the association between low SES and raised BP in 
children and adulthood (125). 
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1.2.3 Tracking of blood pressure from childhood to adulthood  
According to Twisk (126), tracking is the persistence of a characteristic over time or the ability 
of an earlier measure to predict the variable at a later time point .  There is growing evidence 
suggesting that BP trajectory is established in early life, with childhood BP tracking into 
adulthood (127, 128). Chen and Wang demonstrated that tracking of BP between childhood and 
adulthood is positive, moderate and sex specific. They further reported that tracking coefficients 
were stronger with increasing baseline BP (127).  
 
In support of the evidence on BP tracking,  a 15 year longitudinal study of South Korean children 
aged 7-16 years who completed 12 assessments between 1989 and 2004, reported moderate 
tracking coefficients for both ambulatory BP (r=0.30-0.59) and office BP (SBP: r=0.54, DBP: 
r=0.46). They also found out that BP tracked better in boys than girls (129).  Another report on 
Greek school children followed up over 7 years reported a high prevalence of pre-HTN (22.9%,) 
and HTN (24.1%, ) with forty-four percent of the children who had elevated BP (≥90th percentile 
for age, sex, height) at age 9 years remaining in that percentile at age 16 years.   Furthermore, 
tracking coefficients were significantly higher in boys than girls (0.38 vs 0.30) with BMI and 
baseline BP being the major predictors of BP tracking (10).  
 
There is evidence to suggest that though BP tracking depends on the methodological 
considerations like type of instrument used to measure BP, number of BP measurements and age 
at baseline, it is also related to gene-environment interactions (9).   The Odense Schoolchild 
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prospective study in Denmark reported odds ratios (OR) of remaining in the upper BP quartile 
ranging from 1.6-2.4 and 2.1-3.1 for DBP and SBP, respectively, and that relative weight gain or 
weight change predicted BP tracking over the 11 years from childhood to adulthood (130). 
 
Biological factors, socioeconomic status and behavioral factors have also been reported to be 
related to BP tracking between childhood and adulthood (131).  Most recent evidence has 
emerged that modifiable factors like diet, alcohol intake and BMI may be crucial in BP tracking. 
The study by  Kelly et al (132),  found out that Australian children who had elevated BP had 
35% increased risk persisting in that status in adulthood compared to the normotensive. 
Furthermore, the individuals who had reverted to the normotensive BP status in adulthood from 
the elevated BP group had significantly dropped in BMI z-score, alcohol intake z-score, had 
increased their vegetable intake and had experienced an upward social mobility relative to their 
counterparts in the persistently elevated BP status over the follow up period.  
 
In spite of the growing body of literature to support BP tracking from childhood through 
adolescence, there are conflicting studies reporting ranges from negative to positive tracking 
coefficients (127, 133), while others report no or conflicting sex differences (133, 134) and some 
suggesting that the tracking coefficients are too low to be of any clinical relevance (128). The 
majority of longitudinal studies on tracking of BP were conducted elsewhere and not in Africa, 
hence they may not be generalizable to the African context or population. 
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1.2.4 Life course socioeconomic status and blood pressure and hypertension risk 
Socioeconomic status is an established determinant of health across the life course. According to 
the WHO, the environment in which children are born, raised and get older influences their 
health trajectory (135). There is evidence to suggest that social gradients in cardiovascular 
disease risk and hypertension emerge as early as in childhood (136). However, these reports 
assume socioeconomic status is static in nature by using a single measure of SES at one time 
point.  Social epidemiology has now adapted a life course approach to understand the influence 
of socioeconomic status over time on health using three models: the social origins, social 
mobility and the cumulative models. We found most studies from HICs like USA, Netherlands, 
UK, Finland, and Sweden, one from a LMIC, Brazil and none from Africa testing these models 
(Table 1-5).   
 
Most of the studies focus on the accumulation model and the social origins hypothesis and 
reported on the social mobility model. Despite a huge body of epidemiological evidence 
supporting the social origins of raised BP in later life, owing to the work by Barker and 
colleagues (125, 137-139), there is still conflicting findings in testing the social mobility model 
on BP. Murray et al highlighted that the influence of life course SES models on CVD risk factors 
like BP may be sex specific. They fitted all the models on CVD risk in British birth cohort of 
1946 and reported that the critical period/social origins model best fitted the men and the 
cumulative model was pronounced in women for CVD risk at 53 years (140). 
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The social origins model states that early life is a critically sensitive period where adverse 
socioeconomic status can influence adult health, regardless of intervening changes in SES (141). 
A Finnish study also reported that childhood SES was related to adult BP independent of current 
SES (138). This may be regarded as over-adjustment or introducing co-linearity by putting two 
highly correlated SES variables in one model, raising questions about the precision of the 
estimates. 
 
The accumulation model states that persistent poverty or low SES sets in motion a cascade of life 
experiences that accumulate over the life course which is detrimental to blood pressure and its 
associated risk factors in later life (31, 140, 142).  A UK study demonstrated that SES in 
childhood as well as in adulthood influences BP, BMI and other metabolic disease risk factors 
(35). 
 
With regards to the social mobility models, change in SES across the life course may be vital for 
later BP. Several studies reported that an upward mobility in SES (Low-High) is related to low 
BP compared to a persistent low SES profile, while a downward mobility (High-Low) has a 
deleterious effect on BP (140, 143), even across generations (144).  In a bid to disentangle the 
three life course models, a case control study was conducted on a sample of men and women 
who has events of myocardial infarction and they established eight SES trajectories. Their 
findings highlighted the importance of upward/downward social mobility and the social origins 
and the cumulative burden of SES (143). 
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Table 1-5 Summary of major findings on the association between life course SES and BP 
First author. Year 
 
 
Study characteristics Main findings and life course SES model supported 
 
 
 
Location Study design Variables and 
Age (years) 
 
Hogberg, L.2012. (144) Sweden 
 
Twin cohort 
study 
Parental SES 
BP at ≥80yrs 
Upward SES change related to lower odds of 
hypertension and downward SES mobility associated 
with higher odds of hypertension in adulthood [social 
mobility model] 
van den Berg, G. 2013 
(125) 
 
 
Netherlands Birth cohort 
study 
Parental SES 
BP at 5/6yrs 
Children from a low parental SES have higher BP levels 
compared to richer children [social origins hypothesis] 
 
 
Poulton, R. 2002. (141) New 
Zealand 
Birth cohort 
study 
SES at7time 
points 
Adult health at 
26yrs 
Childhood SES has long lasting adverse influence on 
health including BP regardless of current SES[cumulative 
model] 
Schreier, H. M.2010. (139) Canada Retrospective 
cohort study 
Grandparent SES 
Offspring BP at 
13yrs 
Low parental SES associated with their child’s offspring 
raised BP [intergenerational social origins model ] 
Kivimaki, M. 2004. (138) 
 
 
Finland Cohort study Baseline at 8yrs 
BP at 42yrs 
Early life SES influences later BP independent of current 
SES through its effect on BMI [social origins hypothesis] 
 
Power, C. 2007 (35) UK Birth cohort 
study  
SES in childhood 
and adulthood 
BP at 45 yrs 
Early life and current SES is related to CVD risk factors 
including BP [accumulation model] 
Chen, E. 2007. (145) USA  10/11 and 
14/15yrs 
Low SES in early life is associated with later health 
outcomes independent of the current SES [Social origins 
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hypothesis] 
Marin, T. J. 2008. (142) USA  Recall life course 
SES  
BP at 14-18yrs 
Early life SES which persists into adolescence is 
associated with highest adolescent BP [accumulation / 
social origins models] 
Murray, E. T. 2011. (140) UK  53yrs Supported the life course SES cumulative model in 
women and social origins model in men 
 
Hallal, P. C. 2012.(146) Brazil Birth cohort 
study 
SES:0 and 11yrs 
NCD:15yrs 
SES trajectories not associated with BP at  15yrs 
Current SES major predictor of NCD risk 
 
James, S. A. 2006.(147) 
 
 
USA African 
American 
Cohort study 
Childhood and 
adulthood SES 
BP at 
 
 
Compared to the stable high SES, the odds of being 
hypertensive were almost 7 times more for the persistent 
low SES and the high-low SES, 4 times more for the low-
high SES. [accumulation model-but inconsistent social 
mobility model] 
Matthews, K. A. 2002. 
(148) 
USA 
(black/white) 
Cohort study SES at 0, 2,5, 
7,10yrs 
BP at 18-30 yrs 
Decline in SES trajectory  related to incident 
hypertension[social mobility model] 
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1.2.5 Early life growth and life course blood pressure 
A large body of epidemiological evidence on the developmental origins of health and disease 
(DOHaD) hypothesis has confirmed that the early life environment may be crucial in setting 
pathophysiological processes that determine BP in later life (149, 150). The DOHaD hypothesis 
recognizes that both prenatal and early postnatal life may be critical periods for the development 
of high BP. However, it is not clear whether these findings hold for life course longitudinal BP 
patterns. The purpose of this review was to identify key studies on longitudinal BP trajectories 
from childhood to adulthood, and assess their relationship with early life factors such as growth 
and SES (Table 1-6). 
 
Blood pressure trajectories-overview and summary of studies 
In the summary table of studies on predictors of life course BP , the majority of the longitudinal 
studies are from the USA (151-157), UK (158-161), the Caribbean(162), Australia (163), Italy 
(164), and none from Africa.  Most of the studies reported longitudinal BP from childhood (153, 
154, 156, 158, 162, 165) but some of these explored the influence of early life factors on 
longitudinal BP (152, 154, 155, 159, 163).  The studies highlighted that longitudinal BP patterns 
vary according to family history of high BP , SES, physical inactivity and dietary intake (154), as 
well as maternal gestational hypertension (159).   
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The Bogalusa heart study reported that low birth weight was associated not only with later BP 
but also with its rate of change and variability over approximately 25 years, suggesting that over-
activation of the sympathetic nervous system in utero due growth faltering may be an underlying 
mechanism linking birth weight to life course BP.  In addition, this study also found black 
children had higher BP variability over time compared to white children (152). This was also 
supported by Daniel and colleagues, who reported that the rate of BP change in black girls was 
significantly higher than that of white girls. They also highlighted that BMI as an independent 
predictor of the change in SBP over time especially in children who were obese, tall and had 
entered puberty earlier (153) 
 
There is evidence that weight gain in infancy is related to life course BP.  An Australian birth 
cohort study of children followed up from birth until age 17 years also reported that accelerated 
infant weight gain predicted hypertension at 17 years independent of size at birth. This cohort 
study in Western Australia following up children from birth to 17 years of age on eight occasions 
used fractional polynomials based on linear mixed models to model longitudinal patterns of BP 
(163).  
 
A USA study of children of Black (n=1213) and White (n=1166) girls aged 9/10 years at 
baseline  who were followed up to age 14 years reported that BP increased with age, greater in 
Black girls compared to White girls over the course of 4 years.  It also reported that height was 
an independent predictor of age-related changes in BP, even after adjusting for puberty and BMI. 
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Changes in BP were higher in black girls who were obese and tall, and had sexually matured 
earlier (153). The major strength of this study was that it had low attrition rates (<20%), but it 
only focused on girls limiting its ability to extend the findings to boys who have being reported 
to be at higher risk of having raised BP.    
 
The Coronary Artery Risk Development in Young Adults study (CARDIA) from young 
adulthood (18-30 years) in 1998/1999 through to 2010/2011 in Black and White individuals 
reported 5 trajectories of BP classified as: low-stable, moderate-stable, moderate-increasing, 
elevated-stable and elevated-increasing. Participants who were women, White, highly educated 
and those who had fewer con-current risk factors were in the low-stable group.  The individuals 
in the rapid increasing compared to stable groups were more likely to be African-Americans, 
having higher BMI and were smokers (166). 
 
Another study by a UK birth cohort born in 1946 was followed up for 53 years, over 20 time 
points, to characterise BP in midlife. This study reported two latent classes for BP in men and 
three classes for women DBP, and three classes for pulse pressure for both sexes. They found out 
that participants in the normal SBP trajectories had higher birth weight, were taller at age 7 years 
and had a low BMI at 36 years. The “increaser”-group for SBP but not DBP, was associated with 
a persistent low life course SES and physical inactivity was associated with the “increaser” group 
in SBP and DBP (161). 
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Another cohort study (Project HeartBeat!) of childhood BP in which almost 700 children aged 8, 
11 or 14 years at baseline were followed up every four months for four years to describe 
longitudinal patterns of BP noted that SBP rapidly increased between ages 8 and 16 years before 
levelling off, with the slope being steeper for boys compared to girls without clear ethnic 
differences. On the other hand, clear ethnic differences were noted in the DBP curve with black 
children having higher means at all ages and the mean DBP was higher in boys than girls but 
there were no sex and ethnic differences in the rate of change (slope) of DBP.  The SBP and 
DBP trajectories were significantly predicted by central and overall adiposity; in addition, fat-
free mass was associated with SBP (157).  
    
Methodological considerations in modeling longitudinal BP 
Longitudinal analyses of BP compared to cross sectional analyses harness the change of BP over 
time or age.  To determine the changes in BP over time requires repeated measures on the same 
individuals on at least two occasions.  The main rationale of these longitudinal studies is to 
establish the changes of BP over time (at individual and/or intra-individual levels) and analyses 
of the determinants of these changes (ref.  Some of the methods used to analyse longitudinal BP 
were highlighted in Table 1.5; namely: latent class growth mixture modeling (153, 164, 167), 
generalised estimating equations (GEE) (159, 165) and multilevel modeling (151, 155-158, 162).  
 
The majority of the studies have used multilevel modelling which is sometimes referred to as 
mixed effect models with at least two levels; first level being occasion or time point and the 
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second level being the individual participant. Growth curve modeling is used to fit an 
unconditional model that estimates a curve of the development of BP over time using the mean 
(average growth for a population) and covariance structure (variance of growth).  However, this 
method assumes all children follow a uniform pattern of BP changes with time (168).    
 
Another method used in these studies, is finite mixture modelling using either latent class growth 
mixture modeling (GMM) in Mplus (169, 170) or group-based trajectory modeling(GBTM) 
using SAS Proc traj (171). These two methods identify clusters of individuals following a similar 
developmental pattern of a variable of interest called trajectories. A major difference between 
GMM and GBTM is that GMM assumes that a population distribution has two or more 
trajectories where each represents a mean growth curve and allows the intercept and slope to 
vary at individual level but in GBTM the level and change of BP is set at zero just like in Latent 
class growth analyses (LCGA) (172). 
 
Given the dynamic nature of BP within any paediatric population characterised by different 
percentiles for age, sex and height, we would also expect to find heterogeneity in longitudinal BP 
and clusters of individuals within certain age, sex and height-related changes in BP.  Growth 
mixture modelling relaxes the assumption of one growth curve by allowing free parameter 
estimates across unobserved values thereby assigning individuals to subgroup latent classes. 
However,  when running complex models like adding classes, covariates may add computational 
time and convergence issues with improper solution and overall model instability hence it is not 
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uncommon to resort to estimate the level of change rather than the rate of change or export the 
latent classes to other software packages such as STATA, SAS, SPSS or excel for further 
analyses (173).  
   
Statistical packages like Mplus and SAS proc traj use maximum likelihood estimations provided 
data is missing at random (MAR) (174).  In addition, the models have to take into account key 
factors that influence the age-related changes in BP in a growing child, for example height.  
Adding all these variables into a model tends to introduce complexity and model specification 
becomes arbitrary especially in finite mixture modeling.  
 
The choice of number of latent classes or trajectory groups may be informed by research 
questions, model parsimony, proportions in each class and tests for model fit like the Bayesian 
information criteria (BIC) class posterior probability and proportions (173). The BIC is a good 
indicator of number of classes for model fit; the smaller the BIC the better the model fit.  It takes 
into consideration the likelihood of the test and the number of parameters in the model hence the 
more complex the model becomes the lower the BIC. In addition, the best model fit will have a 
high entropy, posterior probabilities and mode than 1% of total counts in each latent class(175).   
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Table 1-6 Early life predictors of life course BP trajectories. 
 
Author(reference) Study location Age range (yrs) 
Longitudinal 
analyses 
Main findings 
Bonati, M. T.2014 (164) Italy 
≥5yrs followed up 
for 25 years 
3 time points Mplus: GMM 
Two distinct trajectories  
Chen,W. 2012 (152) 
USA 
Bogalusa heart 
study (all 
ethnicities) 
4-17yrs followed 
up over 25yrs 6-15 
measurements 
Growth curve 
modelling(GCM) 
SBP fits cubic terms. 
Low birth weight 
inversely associated with 
SBP variability, rate of 
change over time 
Hlaing, W. M. 2006 (154) 
USA(African 
American(AA) 
and caucasian 
6-9yrs followed up 
for 12 years , 5 time 
points 
Non-linear mixed 
models(NLME) 
SBP growth velocity is 
greater in: boys than girls, 
AA vs non-AA. 
BP trajectory vary by 
SES, diet, physical 
activity and family history 
of HTN 
Howe, L. D.2013 (158) 
UK 
Avon 
longitudinal 
study(ALSPAC) 
followed up from 6  
to 17 yrs 
Multilevel 
modelling 
No association of BMI 
SNPs and changes in SBP 
Huang, R. C.2015(163) Australia 0 to17yrs  
Linear mixed 
modelling 
Decelerating adiposity 
from birth is related to a 
declining life course BP 
towards the normative 
range 
Kerner, B. 2009.(176) Framingham 25yrs at baseline Mplus :GMM 3 latent classes identified 
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Heart Study over 30 year follow 
up at 4 time points 
(entropy~0.66) and cubic 
terms for SBP 
Nichols, S.2012.(162) 
Carribean: 
Trinidad and 
Tobago 
11 yrs at baseline 
followed up until 
18years  
multilevel mixed 
regression 
BMI, body fatness and 
weight are the main 
predictors of sex-specific 
BP changes 
Staley, J. R.2015.(159) UK 7-18yrs 
Linear spline 
random-effects 
models. 
Maternal gestational HTN 
predicted high offspring 
BP trajectories 
independent of birth 
weight 
Strand, B. H.2012. (160) UK 36,43,53 yrs Mixed Models 
Childhood SES important 
for rate of change of 
adiposity and SBP 
Su, S.2015. (155) USA 
5 to 38 yrs (13 time 
points)  
Individual growth 
curve modeling 
(GCM)  
Adverse experiences  
associated with higher BP 
trajectories  
Tielemans, S. M.2015. (167) 
Men from 
Minnesota study 
(USA) & 
Zutphen study 
(Netherlands) 
Minesota study  
(45-55yrs) 
Zutphen study   
(40-60), followed 
over 10yr period  
with annual BP 
measurements 
Group-based 
Trajectories 
modeling(GBTM): 
SAS proc traj 
Identified four distinct 
trajectories for SBP and 
DBP 
Wang, X.2006.(156) USA 7-30 yrs 
Multilevel growth 
models 
BP trajectories are sex and 
ethnic group specific 
McGavock, J. M.2007(165) Canada 5-19 yrs 
Generalized linear 
models 
Children with higher BMI 
gained greater SBP 
change and grater stroke 
volume 
Briollais, L.2003 (151) 
USA 
Framingham 
Analyses restricted 
to 25-75 yrs at 4 
Multilevel 
modelling 
The SBP intercept and 
slope were significantly 
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heart study time points predicted by BMI and 
several specific regions on 
chromosomes 1,8,17. 
Daniels S.R. 1998 (153) 
USA 
AA and White 
American girls 
9/10yrs at baseline, 
followed up 
annually until 14 
yrs 
Generalised linear 
models (GEE) 
BMI an independent 
predictor of SBP and DBP 
over time especially in 
girls who are tall and 
obese and reached sexual 
maturity earlier. 
Wills A.K. 2012. (161) UK birth cohort 
Started in 1945 up 
to 53yrs with over 
20 time points GMM: Mplus 
Entropy>0.78. 2 classes 
for men BP, while 3 
classes for women. SES 
key determinant in the 
‘increaser’ SBP class 
Labarthe D.R 2009. (157) 
USA: Project 
heartbeat! 
Aged 8/11/14 at 
baseline followed 
up for 4 years with 
measurements 
every 4months 
Multilevel 
modelling : 
MLwiN 
SBP (cubic terms), 
DBP4(quadratic 
terms).BP rate of change 
higher in boys than girls 
and related to central and 
overall adiposity 
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1.2.6 Summary of the literature review 
This literature review has highlighted a number of issues with respect to BP in children and 
adolescents.  The prevalence of elevated BP in children and adolescents seems to be rising and 
tracks into adulthood.  Age, sex, height and early life growth and environmental factors are the 
major determinants of BP in paediatric population.  Global estimates are still unknown due to a 
number of factors like differences in definition and classification of hypertension in childhood, 
methodological issues in measurement and assessment, and lack of routine inclusion in 
paediatric visits.   
 
Research also shows that upward SES mobility has a protective effect while a downward SES 
mobility has a deleterious effect on BP, particularly in adulthood and persistent low SES is 
associated with high BP. There are various methods of evaluating the change of BP over time, 
and birth weight, sex, socioeconomic status, weight gain or BMI are related to the level and 
change of BP over time. 
 
1.2.7 Gaps in the literature 
This review has highlighted that BP tracks from childhood to adulthood and despite a large body 
of evidence on BP tracking, the research findings from various parts of the world remain 
inconclusive about tracking of BP, possibly because of varying methodological issues in BP 
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assessment in paediatric populations, or varying geographical or environmental background of 
studies.  
   
Some of the studies evaluating BP tracking from childhood overlooked children at high risk at 
baseline (those with BP≥90th percentile for their age, sex and height) (128). This limits the 
generalizability of their findings to at risk population who have been reported to be at higher risk 
of developing hypertension and early-onset of cardiovascular injury. A few studies reported the 
independent influence of BMI on BP tracking. In light of the growing obesity epidemic amongst 
South African children and adolescents, there is need to evaluate whether BP tracking is 
mediated by BMI.  
 
Social determinants of raised BP are well established, however the evidence for the influence of 
life course SES on BP is still scarce worldwide, especially reports on the influence of SES 
mobility/change on BP in adolescents. A number of life course SES models have been tested but 
there is inconclusive evidence on the impact of SES mobility/change and BP. Most of the studies 
were limited to the HICs and may not be generalized to LMICs where socio-economic transitions 
are more prominent. Understanding the impact of socio-economic status change within a South 
African context is important for understanding the impact of post-apartheid policies tailor made 
to improve to the social wellbeing of previously disadvantaged populations. 
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A number of studies assessed BP trajectories and a few of them focused on paediatric groups 
(childhood and adolescence). However, most of these studies overlooked the impact of height on 
age-related changes in BP in a growing child. Furthermore, the majority of the studies evaluated 
the impact of obesity on the age-related BP changes over time. The problem when using BMI as 
a marker for obesity does not disentangle the effect of height from early life weight gain which is 
related to BP via activation of the SNS and RAS (117). 
 
Most studies establishing BP trajectories were based on longitudinal cohort studies and all the 
studies done in South Africa were cross sectional in nature, making it difficult to assess the BP 
profiles over time in paediatric populations and the impact of related factors.  To our knowledge 
there is no study in South Arica that has explored the association between life course SES and 
BP, in spite of the socioeconomic transition underway in this setting.  This study is crucial for 
exploring life course aetiology of high blood pressure from childhood which is an important 
window of opportunity for interventions since the early life period is a period where humans is 
capable of  adapting to environmental cues.   
 
1.2.8 Relevance and justification 
LMICs are experiencing a rapid nutrition and epidemiological transition characterised by a rapid 
increase in NCDs (177).  These countries are expected to be home to most hypertensive adults in 
the near future unless interventions are implemented to interrupt this development. CVD is most 
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prevalent in midlife (35-64 years of age) especially in LMICs (178), implying that the main risk 
factors may track from early life and manifest in adulthood (179).  
 
Owing to the increasing epidemic of obesity in childhood, a risk factor for hypertension, 
evaluation of blood pressure in children has become a major public health concern. Therefore, it 
is vital to assess the early life biological (growth) and socio-economic interactions that are 
associated with blood pressure profiles in order to have a better understanding of the aetiology of 
hypertension for primary prevention.  However, there is paucity of longitudinal paediatric data in 
Subsaharan Africa due to lack of funding and prioritisation of paediatric hypertension. 
 
The detection of BP patterns (trajectories) from childhood to young adulthood and evaluating the 
impact of early life growth in An African context may add to the body of evidence from high 
income countries (HICs) which can inform policy around early life interventions targeting BP.  
This has been proven not only to be cost-effective, but also may leave a profound mark on 
reduction in hypertension risk and CVD burden in later life (180). The importance of 
understanding BP trajectories in early life may shed more light in understanding the etiology of 
early-onset of hypertension in Sub-Saharan Africa 
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1.3 Overall aim  
To assess the prevalence and tracking of elevated BP from age 5 to 18 years, investigate the 
relationship of SES change and BP at 18 years, and evaluate the impact of early growth on BP 
changes over time independent of height. 
 
1.3.1 Specific Objectives 
1. To evaluate the prevalence and tracking of elevated BP between ages 5 and 18 years  
2. To assess the association between SES change between infancy and adolescence, and BP and 
hypertension risk at 18 years 
3. To assess the impact of weight gain and linear growth in infancy and mid-childhood on 
distinct BP trajectories for boys and girls between ages 5 and 18 years, independent of height 
 
1.3.2 Research questions and hypotheses 
Research question 1: Does elevated BP track from childhood to adulthood? 
Hypothesis (H0): Elevated BP does not track from childhood to adulthood 
 
Research question 2: Is SES change/mobility related to BP and hypertension risk at age 18 
years 
Hypothesis (HO): There is no relationship between SES change and later BP 
51 
 
Research question 3: Are there any distinct sex specific-BP trajectories between ages 5 and 18 
years? 
Hypothesis (HO): There are no distinct sex specific BP trajectories between 5 and 18 years of 
age  
 
Research question 4:  Is there an association between  early growth and  BP trajectories 
independent of height? 
Hypothesis (H0): Early growth in infancy and mid-childhood is not related to BP trajectories 
independent of height 
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2 CHAPTER 2: METHODOLOGY 
This chapter comprises the study setting and design, data management and analyses plan, and 
ethical considerations.  Data for this study was obtained from the Birth to Twenty cohort which 
is the longest running birth cohort in Africa following up children born in the Soweto-
Johannesburg metropole in 1990. 
 
2.1 Study setting 
This study was conducted in Soweto in the Gauteng province of South Africa, only 15km from 
Johannesburg. Soweto is an abbreviation for South West Townships, which developed over time 
since 1904 to accommodate black gold miners and black people who were displaced from their 
homes in Johannesburg which were designated for whites following the passing of the Group 
Areas Act of 1950 which imposed racial segregation on residential areas.  
 
Soweto comprised of thirty-four suburbs and covered approximately 200km² and as of 1990, the 
population was estimated to be 3 to 4 million people when the cohort commenced (181).  The 
population growth was fuelled by rapid, unplanned urbanization resulting in an ethnically and 
socioeconomically diverse community.  This period was characterized by dramatic political, 
socioeconomic changes in South Africa which had an impact on child health. The study 
commenced in the midst of the racial inequality gap inherited from the apartheid regime 
especially with regards to access to health services, child health and socioeconomic status (182).  
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Figure 2-1  The Map of Soweto, Johannesburg-South Africa 
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2.2  Study design:  Birth to Twenty cohort  
Data for this study came from the Birth to Twenty longitudinal cohort study (BT20) which is a 
prospective longitudinal study of singleton children born in a seven week period between April 
and May 1990 in the Soweto/Johannesburg metropole. Its initial aim was to explore biological 
socioeconomic environment, psychosocial factors and physical measures associated with growth 
and development of urban children, but after age 10 years the study began to explore 
biochemistry, bone health and factors related to metabolic disease risk.  
 
All mothers within the study area who expected to deliver two weeks prior to 23
rd
 of April 1990 
and a week after the 10
th
 of May 1990, and who were resident in the study area 6 weeks after 
delivery were invited to participate.  The study was piloted in 1989 on mothers in their second or 
third trimester of their pregnancy and revealed that approximately 20% of the mothers who 
delivered in the study area were not permanent residents in the study area and 3273 children met 
the inclusion criteria for the BT20 study (181).  
 
2.3  Data collection and management 
A baseline data collection questionnaire was used to gather information on pregnant women 
attending antenatal clinics in the study between March and May 1990 by trained interviewers.  
After delivery, children were followed up at local public health authority baby clinic to collect 
data from hospital birth notification records on delivery which included mothers demographic 
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details(name, contact details, parity, age, marital status and employment), details of  the infant 
(e.g. time, infant sex, ethnicity,  birth weight, gestational age). 
 
 Data were collected on environmental exposures, nutrition, growth and development, access to 
health care and early life risk factors and from age 10 years, body composition, physiological 
measures, risk factors for metabolic diseases like insulin resistance and lipids were measured 
(183).  Attrition rates per annum were on average less than 3% per annum for the cohort (184).  
Data cleaning was conducted by first using the summary statistics to identify outliers and also 
random selection of IDs to cross check with the filed questionnaires. Analyses were conducted 
using appropriate statistical software depending on the research question.  
 
2.3.1  Data collection instruments 
Standard, general questionnaires were used at each data collection point and were piloted and 
validated before commencing each data collection wave.  The questionnaires were administered 
in English by a trained research assistant since most participants understood English. However, 
in rare cases where the participant could only speak their own language, an interviewer whose 
first language matched that particular participant would administer the questionnaire.  The 
socioeconomic status and anthropometry questionnaire section used in this study are presented in 
Appendix 1 
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2.3.2 Measures and procedures 
Anthropometry measures 
Weight, height and blood pressure were part of the general questionnaire administered by two 
research assistants trained on anthropometric measurements; female and male observer for girls 
and boys, respectively.  Weight and height were measured using standard procedures (185).  
Blood pressure was measured by a trained research assistant in triplicates and the details of the 
procedures are presented in the methods section in Chapters 3, 4 and 5.  
 
Socioeconomic status and demographic variables 
Maternal factors such as height, parity, gravidity, marital status and age were collected using a 
socio-demographic questionnaire at recruitment.  Socioeconomic status was based on the number 
of household assets owned by mother of caregiver for example car, fridge, and television.  The 
list of household consumer durables was based on a validated demographic health survey 
questionnaire used in LMICs. Details of the measures and procedures used in this study are all 
outlined in the methods section of chapters 3, 4 and 5. Gestational age for the child was 
estimated based on the maternal report of last menstrual period.  Sex, ethnicity and other 
demographic factors of the child were recorded at birth. 
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2.3.3 Analytical strategy for the study 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-2 Data analysis strategy for the current study 
BP@5yrs            LIFE COURSE BP/height (RQ3)             BP@18yrs 
SES@0-2yrs           LIFE-COURSE SES               SES @ adolescence (16yrs) 
EARLY GROWTH 
-Birth weight/gestational age 
-Weight gain independent of 
height @infancy and @mid-
childhood 
RQ 1 
RQ2 
RQ2 
RQ2 
RQ4 
RQ4 
RQ2 
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Research Question 1 (RQ1): Does BP track from age 5 to 18 years? 
After data cleaning of BP data at every time point, summary statistics were conducted to 
determine the age-, sex- and height-specific prevalence of prehypertension and hypertension 
(elevated BP) using the NHBPEP criteria. Comparisons between using CDC- and the WHO- 
standardized height z scores to define hypertension risk showed no significant differences. 
Children who had reached eighteen years had their BP classified using adult cut-offs from the 
Seventh report of the Joint National committee on prevention, detection, evaluation and 
treatment of high blood pressure (JNC7) : prehypertension (SBP: 120-139mmHg and /or DBP: 
80-89mmHg) and hypertension (SBP: ≥140mmHg and /or DBP≥90mmHg) (186). 
 
Research question 2 (RQ2): Is SES change between infancy (0-2yrs) and adolescence 
(16yrs) associated with BP and hypertension risk at 18 years independent of growth? 
Socioeconomic status in infancy and adolescence was based on household assets ownership and 
a matrix was used to define SES change using the three tertiles of SES at these two time points. 
The persistent low SES group was designated the reference group. The independent influence of 
growth (birth weight, gestational age, relative weight and height gain at 2, 4, 18 years of age) on 
the relationship of SES change and BP and hypertension was explored using multivariate 
analyses.  
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Research question 3 (RQ3): Are there sex- and height-specific BP trajectories between ages 
5 and 18 years? 
To address RQ3 which sought to determine the BP trajectories, finite mixture modelling 
techniques in Mplus and SAS proc traj in STATA were explored. The main objective was to 
identify meaningful subgroups of individuals following similar age-related level (intercept) and 
change (slope) of BP from age 5 to 18 years.  
 
The first step was to export data in compatible format to Mplus, and basic exploratory analyses 
were run to give summary statistics and correlation matrices and to check for any atypical trends 
of missing data and outliers.  The second step was to fit the appropriate model. We used the 
intercept, slope, quadratic and cubic terms for black children in the sample for boys and girls, 
and SBP and DBP, separately using LCGA and GMM to reach the optimal solution in Mplus.  I 
found that three classes for each sex and for SBP and DBP fit this data well using the model fit 
criteria of high posterior probabilities, and meaningful distinct classes from graphical displays 
and low BIC. However, I encountered convergence issues when running multinomial logistic 
regressions with height as a time varying covariate so I ended up using group based trajectory 
modeling (GBTM) with a STATA plug-in macro developed by Jones and Nagin (187). 
 
For this study , we explored  2, 3, 4, and 5 class models for both SBP and DBP by sex with and 
without time varying covariates (height between ages 5 and 18 years) to identify the best model 
fit based on low BIC, posterior probabilities (>0.7) and the nature of the trajectories.   
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Research question 4 (RQ4): What is the impact of early growth on BP trajectories 
independent of height between ages 5 and 18 years? 
 
GBTM can be used to run models with both time varying(height between ages 5 and 18 years) 
and time constant covariates(SES, maternal factors like parity) resulting in trajectories showing 
probability of group membership over time.  The output has an estimated intercept, regression 
coefficient, a Wald test for statistical significance and BIC.  Details of the analyses are found in 
chapter 5 statistical analyses section. 
 
2.4  Ethical considerations 
Informed consent was sought on behalf of the participant when they were minors, from the 
primary caregivers or parents prior to data collection at each data collection visit. At age 18 
years, the participant consented to participate in the study.  Ethics clearance for this particular 
study was obtained from the University of Witwatersrand Human Research Ethics Committee 
(Certificate no: M130556 –Appendix 2).  
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3 CHAPTER 3:  BLOOD PRESSURE TRACKING IN URBAN BLACK 
SOUTH AFRICAN CHILDREN: BIRTH TO TWENTY COHORT  
Kagura Juliana
1*
, Adair Linda S
1, 2
, Musa Mogi G
1
, Pettifor John M
1
, Norris Shane A.
1 
(Published: BMC Pediatrics. 2015; 15:78) (188) 
 
3.1 Background  
The increasing prevalence of childhood and adolescent hypertension is rapidly emerging as a 
global public health concern (189, 190). Although the condition was rarely diagnosed in children 
due to the lack of its inclusion during routine screening, there is now growing evidence to 
suggest that essential hypertension in adulthood has its roots in childhood and adolescence (191, 
192).  Epidemiological evidence from longitudinal cohorts such as the Young Finns study (193), 
Bogalusa Heart study (194), Muscatine study (134) and the Kangwha study (129) showed that 
BP tracks from childhood to adulthood.  In line with this, a systematic review and meta-
regression analysis of a various paediatric cohorts by Chen and Wang (127) reported moderate 
BP tracking from childhood to adulthood, with overall tracking coefficients stronger for systolic 
blood pressure compared (SBP=0.38) to diastolic blood pressure (DBP=0.28) with marginal sex 
discrepancies. 
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The majority of longitudinal studies following blood pressure patterns from childhood to 
adulthood comes from high income countries (HICs), there being a paucity of similar studies 
from low-middle income countries (LMICs) like South Africa where epidemiology of 
hypertension appears to be unique.  The most recent global report from the WHO-SAGE study 
ranked South Africa highest in prevalence of hypertension in people aged 50 or older (78%) 
(195). The Heart of Soweto study reported a hypertension prevalence of 55% among adults aged 
52.8 years (196).  A few studies in South Africa have assessed blood pressure profiles in children 
and adolescents and have reported a prevalence of hypertension in black children ranging from 
1% to 25.9% (54, 62, 197, 198).  However, these studies were cross sectional, mostly conducted 
in rural settings and were not designed to establish tracking of elevated blood pressure into late 
adolescence.  
 
The longitudinal tracking of BP may provide insight into the aetiology of essential hypertension 
in adult Black South Africans.  Until now, no studies have adequately addressed this because of 
the lack of longitudinal data on BP in children and adolescents in the same setting. The present 
study aims to (1) describe the prevalence of elevated BP in a population of urban black South 
African children and adolescents aged between 5 to 18 years, (2) assess tracking of BP from 
childhood to at 18 years of age.  
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3.2 Methods 
3.2.1 Study Sample  
Data for this study are from the Birth-Twenty cohort, which is following singleton infants, born 
in the Soweto-Johannesburg Metropolis (N=3273) in 1990. Mothers of these children were 
residents of Soweto recruited from antenatal clinics who were expected to deliver within the 
seven-week period between 23 April and 8 June 1990.  Follow up was done telephonically or 
through field visits and contact with parents/caregivers and participants were maintained 
between data collection time points by newsletters and birthday cards.  The details of recruitment 
and cohort attrition have been described elsewhere (183).  For this study, only black participants 
were selected who had anthropometric measurements and BP assessments in 1995 (n=1026), 
1998(n=1024), 2002(n=1351), 2003(n=1391), 2005(n=1624), 2008(n=1587).  
 
3.2.2 Measures 
Anthropometry  
Trained research assistants carried out anthropometric measurements. Weight was measured on a 
digital scale to the nearest 0.1kg with participants in light clothes without shoes.  Standing height 
was measured by means of a wall-mounted stadiometer (Holtain, UK) to the nearest 0.1cm.  
Body Mass Index (BMI) was computed using the formula: weight (kg) divided by height squared 
(m
2
) and converted to WHO BMI z scores for age in STATA.  
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Blood Pressure assessment 
Blood pressure was measured using an Omron 6 automated machine (Kyoto, Japan) from the age 
10 years onwards; while a Dinamap Vital Signs monitor 1846SX (Critikon, USA) was used at 
age 5 years. Three individual measurements were taken at intervals of 2 minutes with 
participants in a seated position and using an appropriate cuff size after 5 minutes of sitting in a 
resting position. The first BP reading was discarded and the second and third BP measurements 
were averaged for all the analyses.  We used age, sex and height standardized percentile tables 
for BP classification in children and adolescents in the analysis where BP status was classified 
for each gender and CDC-standardised height percentile as either normotensive (<90
th
 
percentile), prehypertensive (≥90th to < 95th percentile or >120/80 mmHg if <90th percentile) or 
hypertensive (≥95th percentile) using the fourth report from the National High Blood Pressure 
Education Program working group on high blood pressure in children and adolescents ( 
NHBPEP) (47)  as a guideline.  
 
3.2.3 Statistical Analyses 
We used descriptive statistics to assess sex differences in variables, for comparison of 
participants followed up between baseline and age 18 years and to compute proportions of BP 
status at each time point using student t-test for continuous variables and chi square test for 
categorical variables. Pearson correlations were used to assess the tracking of BP from baseline 
at 5 years to the end of follow-up at 18 years.  We used multinomial logistic regression models to 
compute relative risk ratios (RR) to assess the risk of having elevated BP at 18 years of age given 
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an elevated BP status in childhood or adolescence with normotensive status as a reference group 
(RR=1). The probability value for statistical significance was p<0.05 unless indicated and all the 
analyses were done using STATA 11. 
 
Ethical considerations 
Prior to the study, ethical approval was obtained from the Human Research Ethics Committee of 
the University of the Witwatersrand, Johannesburg (M130556). Informed consent was sought 
from parents/caregivers when the participants were minor at the beginning of each data 
collection session. Data on this study is available to researchers on request from the 
Developmental Pathways for Health Research Unit data management. 
 
3.3 Results 
Study characteristics 
Age and sex-stratified mean systolic (SBP), diastolic blood pressures (DBP) and BMI are 
presented in  
Table 3-1. Boys had a marginally higher SBP compared to girls at mean ages 16 and 18 years of 
age (p<0.001).  Girls tended to have slightly higher DBP compared to boys but the differences 
were only significant at mean ages 13 and 14 years (p<0.001).  Sex differences emerged from 
age 13 years to 18 years with girls having markedly higher BMI compared to boys (p<0.001).  
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No differences were noted between those who did and did not have information on 
anthropometry and BP measurements at ages 5 and 18 years, except that those who had 
measurements at both 5 and 18 years of age had marginally lower BMI (Appendix 3) hence BMI 
was adjusted in all the models. 
Table 3-1 Sex differences in BP and BMI in urban black South African children by mean age 
Sex Mean 
age(years) 
N SBP(mmHg) DBP(mmHg) BMI(Kg/m²) 
Males 5 503 108(13) 63(8) 16(1) 
 8 506 109(10) 69(8) 16(1) 
 13 643 106(10) 65(8)  18(3) 
 14 659 108(11) 68(9) 19(3) 
 16 779 117(12) 68(10) 20(3) 
 18 766 121(11) 71(9) 20(3) 
      
Females 5 523 108(12) 64(9) 16(1) 
 8 523 109(11) 70(9) 16(2) 
 13 708 106(10) 67(8) 19(4) 
 14 732 107(10) 70(9) 21(4) 
 16 845 110(12) 68(9) 22(4) 
 18 821 115(10) 72(9) 23(5) 
A student’s t-test was used for all analyses and results presented as mean (standard deviations) 
and level of significance set at:*P<0.05; ***p<0.001 
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Prevalence of prehypertension and hypertension  
Table 3-2 shows the prevalence of pre-hypertension and hypertension at the various time points 
in childhood and adolescence.  The prevalence of prehypertension remained fairly constant 
across the ages, ranging from 9.2% at age 8 years to 16.4% at age 16 years in the sexes 
combined.  The prevalence of hypertension in boys and girls combined ranged from 22.4% at 
age 5 years to 15.7% at age 18 years, with the prevalence falling in the intervening years. Sex 
differences in BP status only emerged at age 16 years, with the proportions of boys having 
elevated BP being higher than girls  (p<001).  
 
Table 3-2 Sex-specific BP status in urban black South African children aged 5 to 18 
years 
Age(years) Sex  BP status 
Normotensive 
N (%) 
Pre hypertensive 
N (%) 
Hypertensive 
N (%) 
5 M 
F 
Total 
353(70.2) 
342(65.4) 
695(67.8) 
52(10.3) 
49(9.4) 
101(9.8) 
98(19.5) 
132(25.2) 
230(22.4) 
8 M 
F 
Total 
334(66.3) 
348(66.4) 
682(66.3) 
44(8.7) 
51(9.7) 
95(9.2) 
126(25.0) 
125(23.9) 
251(24.4) 
13 M 490(82.9) 63(10.7) 38(6.4) 
69 
 
F 
Total 
522(79.6) 
1015(81.3) 
67(10.2) 
130(10.4) 
67(10.2) 
105(8.4) 
14 M 
F 
Total 
502(76.1) 
548(74.9) 
1050(75.4) 
75(11.4) 
92(12.6) 
167(12.0) 
83(12.6) 
92(12.6) 
175(12.6) 
16 M 
F 
Total 
466(59.7) 
653(77.2) 
1119(68.8) 
172(22.1) 
94(11.1) 
266(16.4) 
142(18.2)*** 
99(11.7) 
241(14.8) 
18 M 
F 
Total 
552(72.0) 
595(72.2) 
1147(72.1) 
96(12.5) 
98(11.9) 
194(12.2) 
119(15.5) 
131(15.9) 
250(15.7) 
A chi square test was conducted to describe the gender differences in blood pressure status at each age category and  significance:*p<0.05; 
***p<0.001.  Some proportions do not add up to 100% because of rounding off to the nearest 0.1 percentage.  
 
Tracking of blood pressure 
Tracking coefficients are presented in Table 3-3 with the average BMI-adjusted correlation 
coefficients between ages 5 and 18 years for SBP and DBP ranging from 0.20 to 0.57 and 0.17 to 
0.51, respectively. It is noteworthy that all the tracking coefficients remained significant even 
after adjusting for BMI.  Overall, the mean tracking coefficients for SBP were marginally higher 
than those for DBP with inconsistent sex differences in the multivariate models.   
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Table 3-3 Sex specific tracking correlation coefficients for blood pressure from 5 to 18 years of age 
Correlation between 
two mean age 
categories 
Systolic BP Diastolic BP 
 Boys Girls Boys Girls 
 Crude Adjusted Crude Adjusted Crude Adjusted Crude  Adjusted 
5-8 0.26 *** 0.22*** 0.39 *** 0.33*** 0.19 *** 0.18*** 0.21*** 0.17*** 
5-13 0.28 *** 0.20*** 0.27 *** 0.20*** 0.24 *** 0.21*** 0.20*** 0.17*** 
5-14 0.25 *** 0.20*** 0.16 *** 0.16*** 0.22 *** 0.22*** 0.15*** 0.13*** 
5-16 0.22 *** 0.20*** 0.25 *** 0.23*** 0.23 *** 0.26*** 0.26*** 0.25*** 
5-18 0.23 *** 0.19*** 0.18 *** 0.13** 0.23 *** 0.25*** 0.15*** 0.14** 
Average 0.25  0.20 0.30 0.21 0.22 0.22 0.19 0.17 
8-13 0.42*** 0.38*** 0.43*** 0.38*** 0.25*** 0.20*** 0.32*** 0.26*** 
8-14 0.42*** 0.41*** 0.43*** 0.39*** 0.28*** 0.31*** 0.36*** 0.36*** 
8-16 0.27*** 0.30*** 0.40*** 0.44*** 0.18*** 0.17*** 0.31*** 0.30*** 
8-18 0.29*** 0.29*** 0.34*** 0.29*** 0.22*** 0.22*** 0.27*** 0.28*** 
Average 0.35 0.35 0.40 0.38 0.23 0.23 0.32 0.30 
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Simple and multiple linear regressions adjusted for BMI-age z score.  Significant at **p<0.01     ***p<0.001 
13-14 0.53*** 0.61*** 0.60*** 0.61*** 0.53*** 0.55*** 0.58*** 0.62*** 
13-16 0.50*** 0.57*** 0.42*** 0.49*** 0.39*** 0.43*** 0.41*** 0.44*** 
13-18 0.50*** 0.53*** 0.41*** 0.40*** 0.36*** 0.39*** 0.47*** 0.49*** 
Average 0.51 0.57 0.47 0.50 0.42 0.46 0.49 0.51 
14-16 0.53*** 0.57*** 0.47*** 0.54*** 0.48*** 0.51*** 0.46*** 0.49*** 
14-18 0.47*** 0.45*** 0.54*** 0.44*** 0.39*** 0.39*** 0.48*** 0.48*** 
Average 0.50 0.51 0.51 0.49 0.43 0.45 0.47 0.49 
16-18 0.46*** 0.36*** 0.44*** 0.34*** 0.37*** 0.34*** 0.45*** 0.42*** 
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Relative Risk of having Elevated BP status at age 18 years  
Table 3-4 provides the relative risk ratios at each age category for having elevated BP in late 
adolescence. BP status was classified as normotensive (<90
th
 percentile) or elevated BP 
(combining prehypertension and hypertension groups). There is a consistent, significant 
relationship between BP status at each of the ages 5, 8, 13, 14, 16 years and that in late 
adolescence (p<0.001).  Between a third and a half of children who had elevated BP at ages 5, 8, 
13, 14 and 16 years, remained with elevated BP status at 18 years, while approximately 20% of 
children who were normotensive at each age group had elevated BP at age 18 years.  The 
majority of the participants remained normotensive between an earlier time point and age 18 
years (range: 77-80%) while 43.8% (age 5 years) to 63.9% (age 13 years) of those who had 
elevated BP became normotensive at age 18 years.  
 
The relative risk of having an elevated BP at age 18 years for children or adolescents with BP 
above the 90
th
 percentile for their age, sex and height is presented in Table 3-4.  Children who 
had an elevated BP at each of the age categories had risk of between 1.60 (95%CI: 1.29 to 2.00) 
and 2.71 (95%CI: 2.32 to 3.17) of having an elevated BP at 18 years of age compared to their 
normotensive peers (p<0.001 in all adjusted models). Adjusting for BMI only reduced the risk 
slightly. 
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Table 3-4 Relative risk of elevated BP in urban black South African children between childhood and adolescence 
Mean 
Age(years) 
 
BP Status 
BP status at 18 years Relative Risk (95%CI) 
Normotensive Elevated BP Total Crude  BMI-adjusted 
5  Normotensive 461(77.3) 135(22.7) 596(69.4) *** 1(ref) 1(ref) 
 Elevated BP 168(63.9) 95(36.1) 263(30.6) 1.60(1.28-2.00) 1.60(1.29-2.00) 
 Total 629(73.2) 230(26.8) 859(100.0)   
       
8  Normotensive 454(77.2) 134(22.8) 588(66.7) *** 1(ref) 1(ref) 
 Elevated BP 184(62.8) 109(37.2) 293(33.3) 1.75(1.43-2.14) 1.69(1.39-2.06) 
 Total 638(72.4) 243(27.6) 881(100.0)   
       
13 Normotensive 719(78.4) 198(21.6)  917(81.5) *** I(ref) 1(ref) 
 Elevated BP 91(43.8) 117(56.3) 208(18.5) 2.70(2.28-3.20) 2.56(2.16-3.04) 
 Total 810(72.0) 315(28.0) 1125(100.0)   
       
14 Normotensive 770(80.1) 191(19.9) 961(75.2)*** 1(ref) 1(ref) 
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 Elevated BP 147(46.5) 169(53.5) 316(24.8) 2.84(2.43-3.32) 2.71(2.32-3.17) 
 Total 917(71.8) 360(28.2) 1277(100.0)   
       
16 Normotensive 830(80.0) 207(20.0) 1037(69.4)*** 1(ref) 1(ref) 
 Elevated BP 246(53.7) 212(46.3) 458(30.6) 2.34(2.01-2.72) 2.28(2.00-2.65) 
 Total 1076(72.0) 419(28.0) 1495(100.0)   
       
Chi square test was used to assess the difference in BP status at a given two time points and results presented as proportions:  n (%). Some proportions do not add up to 100% because of rounding off to 
the nearest percentage and level of significance set at ***P<0.001 
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3.4 Discussion 
The present study reports a high prevalence of elevated BP, which persists into late adolescence, 
in a longitudinal cohort of urban black South African children and adolescents. Approximately 
one-third to a half of children who were hypertensive at some time during childhood and 
adolescence were hypertensive at age 18 years. The risk of having elevated BP at 18 years of age 
was lowest at age 5 years and highest at age 14 years.  
 
We reported an overall prevalence of hypertension (>95
th
 percentile) of 22.4% and 24.4% at ages 
5 and 8 years, respectively.  The prevalence of hypertension in children and adolescents reported 
in other studies varied considerably from 0% to as high as 25.9% in children aged 6 to 15years of 
age (62, 65, 199).  A study from the North-West province of South Africa reported a prevalence 
of hypertension of 25.9% in Grade one learners aged 6 years based on one visit and an average 
of three BP measurements classified according to NHBPEP (198).  Studies from other countries 
in the Sub Saharan Africa have reported a lower prevalence of hypertension in children than the 
current study; Zambia (6.9% in boys and 6.1% in girls) (60), Congo (10.1%) (70), Nigeria 
(4.7%) (69). This could possibly be attributed to the epidemiological transition taking place in 
South Africa and which is characterized by a shift from under-nutrition to overnutrition, and by 
refined foods and high salt intake in children and adolescents which are risk factors for elevated 
BP in children, but this needs to be tested within our population (200).  It is noteworthy that 
though many studies from HICs have reported a prevalence of hypertension in children as low as 
3% (63, 201), it is reported that the prevalence of hypertension is high in Hispanic (23.6%) and 
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African-American (17,2%) populations aged between 8 and 13 years (65)  which is comparable 
to our study.   
 
Our results suggest that there is a positive weak-to-moderate tracking of BP in this cohort which 
is comparable to other studies; with adolescent baseline BP tracking better compared to 
childhood BP (202, 203). Similar to our findings,  Bao and colleagues (203) reported tracking 
coefficients varying from 0.36 to 0.50 for SBP and 0.20 to 0.42 for DBP in children ages 5 to 14 
years after a 15 year-follow-up period, with BMI having no effect on the degree of tracking. 
Similarly, Toschke et al (128)   reported a pooled tracking coefficient of 0.37 from 29 cohort 
studies of children aged 10 to 20 years.  Consistent with other studies, we found out that SBP 
tracked better than DBP (133, 204). Clarke et al (204) reported tracking coefficients in SBP and 
DBP of 0.30 and 0.18, respectively.  
 
Existing evidence on sex differences in BP tracking is conflicting; some studies have shown no 
major differences (133, 205) whereas others have reported that SBP track better in boys (0.38)  
compared to girls (0.30) but girls (0.22) have higher tracking coefficients compared to boys 
(0.20) for DBP (10).  A previous review on blood pressure tracking from childhood to adulthood 
found little sex differences in BP tracking with men having stronger tracking for SBP and DBP 
(127).  We have shown that sex differences in BP tracking become more pronounced in 
adolescent baseline ages compared to childhood; with SBP tracking better in boys than girls and 
DBP tracking better in girls than in boys. The mechanism underlying these sex discrepancies in 
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BP tracking before or during adolescence are not fully understood and require further research 
though some authors have suggested that pubertal development might influence BP tracking 
especially in adolescence (206). 
 
We found that about 36% of the children who had elevated BP at ages 5 or 8 years retained the 
elevated BP status at age 18 years of age. These findings are consistent with a recent report from 
a Germany study of 13 261 both sick and healthy children aged between 3 and 21 years, 
attending an outpatient clinic, in which the persistence of elevated blood pressure was as high as 
35.6% in a six-year follow-up study(207).  Similar results have been reported from the USA on 
data from the National Childhood Blood Pressure database (208).  The Bogalusa Heart Study of 
children initially aged 5-14 years found that of those who were clinically diagnosed with 
hypertension after 26 years, 48% and 41% had elevated SBP and DBP at baseline, respectively 
(202).   
Some longitudinal studies used odds and hazard ratios (HR) to assess the association between an 
earlier BP status and the end of follow up BP status (>90
th
 percentile). For instance, the Fels 
Longitudinal study reported that the odds of having elevated BP as an adult aged 30 years or 
above given a childhood elevated BP status (5 to 7, 8 to 13 or 14 to 18 years of age)  ranged from 
1.8 to 4.4 (209). A school-based screening program from Texas, USA reported that the 
likelihood of having hypertension after a 2-year follow up in children aged 10 to 19 years was 
almost 5-fold; HR:4.89(95%CI:1.48-16.19) (210).   
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Consistent with previous studies, girls had significantly higher mean DBP than boys at ages 8, 
13, 14 and 18 years; but boys had higher SBP than girls between ages 14 and 18 years and these 
sex differences became more apparent as the adolescents grew older.  BMI was considered as a 
covariate in tracking of blood pressure. Sex differences emerged in BMI in adolescence with 
girls having higher BMI compared to boys.   
 
A positive feature of this study is its longitudinal design which has confirmed in a LMIC setting 
results similar to those reported in HICs. We also made use of automated BP monitors, which 
reduce observer bias compared to the sphygmomanometer that has been reported to be prone to 
subjectivity in detecting the Korotkoff sounds in children (211).  Furthermore, we classified BP 
status by sex, height and age of the child, which are the main confounders of BP status in 
growing individuals. We acknowledge that our study had a limitation in that BP classification 
was different to the NHBPEP recommendations that children and adolescents should only be 
classified as pre-hypertensive or hypertensive based on an average BP from three measurements 
on three different occasions in the same year. 
 
3.5 Conclusions 
This longitudinal study of BP in urban black South African children confirms the existence of 
elevated BP in a significant proportion of children and adolescents.  We also reported that the 
majority of children (77 to 80%) who were designated normotensive remained in that status 
showing that in as much as it is vital to identify the children at risk of having persistent elevated 
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BP, it is also important to fully assess the profiles of the children who remain normotensive or 
who had elevated BP initially but reverted to the normotensive status at 18 years of age to inform 
early life intervention programs. The implications of these findings are that early identification of 
children with elevated BP and associated risk factors through pediatric screening programs and 
timely interventions could be vital to reduce the risk of elevated BP in adulthood. In addition, 
more research is required to assess the feasibility and the cost effectiveness of the screening and 
intervention programs in LMICs such as South Africa. 
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4 CHAPTER 4:  ASSOCIATION OF SOCIOECONOMIC STATUS 
CHANGE BETWEEN INFANCY AND ADOLESCENCE AND BLOOD 
PRESSURE IN SOUTH AFRICAN YOUNG ADULTS: BIRTH TO 
TWENTY COHORT 
Kagura Juliana, Pisa Pedro T,  Griffiths PL, Adair Linda S, Pettifor John M, Norris Shane A.
 
(Published: BMJ Open. 2016; 6:3)(212) 
4.1 Background  
Hypertension is a major public health problem and an independent modifiable risk factor for 
cardiovascular diseases, which is increasingly becoming a problem in low-to-middle income 
countries (LMICs)(8).  Research has documented that socioeconomic status (SES) influences 
blood pressure (BP) with low SES being predictive of elevated blood pressure in children (213) 
and adulthood (214, 215). In addition, early life factors like birth weight and weight gain may 
influence the SES change-BP relationship since children from low SES families are likely to be 
born small and at higher risk of excessive weight gain and high blood pressure (216, 217).   
 
Most of the evidence on social inequalities in blood pressure comes from longitudinal and cross 
sectional studies and assumes SES is quite stable over time. However, SES  across an 
individual’s lifespan is dynamic in nature especially in societies experiencing socio-political 
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transitions like South Africa (218), hence the SES-BP relationship might change even within 
short periods of time in the early life-course (219). 
 
There has been growing interest in a life course approach to social inequalities in  hypertension 
epidemiology, owing to the evidence that high blood pressure in adulthood evolves from early 
life; hence the importance of early life environment as a factor influencing the development of  
hypertension.  Life course approaches assume that an individual’s health is influenced by 
dynamic biological and social exposures throughout a life span and that the exposures may not 
be static over the entire life course (31).   There are three major conceptual models proposed in 
life course social epidemiology: social origins (critical periods/latent effect) model, accumulation 
model and the social mobility model (141, 143). 
 
The social origins hypothesis states that early life is a critical period for biological programming 
where low SES plays a preeminent role in programming health, with children growing up in a 
low SES environment having raised BP (138), independent of their SES in intervening years 
(142). We have previously reported finding no relationship between SES in infancy and blood 
pressure in this cohort of South African adolescents in contrast to the social origins hypothesis 
(220).  The accumulation model proposes that persisting low SES is detrimental to health.  
Research on cardiovascular disease risk indicates that low SES in early life has an additive effect 
on risk factors like blood pressure (32, 140).  The social mobility model suggests that upward 
social mobility has a protective effect on hypertension risk while a downward SES change is 
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deleterious to cardiovascular disease risk in adulthood (147, 148).  Hogberg and colleagues 
reported that intergenerational upward social mobility from low SES was associated with 18% 
reduction in hypertension risk in a Swedish Twin study of 12 030 adults (144).   
 
The social mobility model has been widely used in life course social epidemiology. However, 
there is limited literature on social mobility and hypertension, especially among children and 
adolescents, and most of the studies have concentrated on the intergenerational effect of social 
mobility on blood pressure using parental and participants’ occupation or education to determine 
life course SES or have used later adulthood BP as an outcome. None of the studies adjusted for 
initial SES and weight gain, making it difficult to disentangle early life SES environmental 
effects and weight gain from social mobility effects (141, 144, 147, 221). 
 
Adolescence is a crucial developmental stage characterized by environmental and social changes, 
and the onset of hormonal and physiological factors that influence physical health outcomes like 
blood pressure.(222) The studies to date have focused on social mobility in high income 
countries, where less variability in experiences of SES over the early life-course exist compared 
to the dynamic SES environments of low and middle income countries (223). 
 
Post-apartheid South Africa has been undergoing a rapid social and political transition. The 
volatility of social environment in the post-apartheid era which has seen improvements in SES in 
previously disadvantaged black populations makes the Birth to Twenty prospective longitudinal 
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cohort a unique and valuable resource to explore the social mobility hypothesis using blood 
pressure as an outcome which is highly sensitive to changing environments.  
 
This study seeks to test the hypothesis that an upward SES change during childhood and 
adolescence would be associated with lower blood pressure in early adulthood. Therefore, this 
study aims to (1) examine the association between SES change and BP and hypertension risk at 
18 years of age, and (2) explore whether the SES change-BP relationship is explained by birth 
outcomes and weight gain between birth and adolescence.  
 
4.2 Methods 
4.2.1 Study design and participants 
Data for this study came from the Birth to Twenty birth cohort (BT20) - a prospective 
longitudinal study of children born in Soweto, Johannesburg, South Africa in 1990.  Details of 
recruitment and enrollment into the cohort study are outlined elsewhere.(183) Data for this study 
were collected at birth, and at ages 2, 4, 16 and 18 years.  For the purpose of this study, only 
black children who had data on blood pressure during late adolescence (18 years), SES data in 
infancy and during adolescence, birth weight and gestational age, weight gain in infancy, mid-
childhood and from mid-childhood to adolescence were included in the analysis (n=838). We 
only selected black children since they comprise the majority of the BT20 study (Figure 4-1).  
Ethics approval was obtained from University of Witwatersrand Human Research Ethics 
Committee (M130556). Informed consent was obtained from caregivers and participants gave 
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their assent at all data collection time points before the participants turned 18 and their consent 
once they had turned 18 years of age. 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 4-1 Flow chart of the study population with SES, growth and blood pressure at 
age 18 years 
Birth to Twenty Cohort in 1990 
Black participants with BP measures 
at 18 years 
BP, SES and all growth 
measures 
Black participants 
N=2568 
SES at 2 and 16 years 
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4.2.2 Measures 
Blood pressure assessment 
Blood pressure was measured in triplicate using the Omron M6 (Kyoto, Japan)  and an 
appropriate cuff size with participants in a seated position after an initial five minute rest, and a 
two minutes rest between each of the three measurements.  An average of the second and third 
measurements was used for the analyses of systolic blood pressure (SBP), diastolic blood 
pressure (DBP) and pulse rate. The mean SBP and DBP were used to calculate mean arterial 
pressure (MAP) using the traditional formula: MAP = [(2 x diastolic) + systolic] / 3. (224) 
Hypertension risk was classified using the age, sex and height specific percentiles from the 
National High Blood Pressure Education Program Working Group on Hypertension control in 
Children and Adolescence, with hypertension being defined as ≥95th percentile and non-
hypertension as ˂95th percentile.(47) 
 
Socioeconomic status change 
We used physical asset-based household SES measures tool in infancy and at 16 years of age 
which utilized a validated standardised questionnaire based on the Demographic and Health 
survey for developing countries (available at: http://www.dhsprogram.com/ ).  The selection of 
an asset-based household SES was inspired by the notion that assets are more dynamic and 
sensitive than other measures, like education and occupation, especially in previously 
disadvantaged populations undergoing rapid economic and social transition.  The physical assets 
SES measures (for example television, car and refrigerator) were assessed by asking the 
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caregiver or participant whether they had the asset in question (Yes/No).  The physical asset 
scores were computed from all the ‘YES’ answers and were categorized into tertiles: low (1), 
medium (2) and high (3) for each of the two time points. Thereafter, nine categories of the social 
mobility model were generated according to the literature and were defined as: low-low(11), 
low-medium(12), low-high(13), medium-low(21), medium-medium(22), medium-high(23), 
high-low(31), high-medium(32) and high-high(33). (225) 
 
Potential confounders and mediators 
Sex, gestational age and birth weight were included from data collected at birth. Weight and 
height at 2, 4 and 18 years were measured using standard procedures. Relative weight gain was 
defined as weight gain independent of height during infancy, at mid-childhood (2-4 years) and at 
adolescence to adulthood (4-18 years)  and was computed as residuals obtained by regressing 
current weight on current height and previous weight and height to deal with the potential multi 
co-linearity between weight and height (226).   We also used SES in infancy as a covariate since 
it was a proxy for early life environment so that the SES change variable represents a true 
measure of social mobility. Because BP in children is age, sex and height specific, we adjusted 
for these three factors in all the models which included SBP, DBP and MAP.   To assess alcohol 
and tobacco use during adolescence, participants at age 17 years were asked whether they had 
taken alcohol or smoked tobacco in the last month/ intake (No/Yes). 
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4.2.3 Statistical analyses 
Chi square tests and t-tests were used to describe the study characteristics by sex and 
hypertension risk for categorical and continuous variables, respectively.  Multiple linear 
regressions were used to assess the association between SES change SBP, DBP and MAP 
adjusting for SES in infancy, birth weight and weight gain in infancy, mid-childhood and from 
mid-childhood to adulthood.  We further adjusted the multivariate models for alcohol intake and 
baseline BP.  Additional exploratory models were run for boys and girls separately (results not 
shown).  We also computed the crude and adjusted odds ratios (and 95% confidence intervals) 
from logistic regressions for the association between SES change and hypertension risk. The 
statistical analysis were performed in STATA 13 with level of significance set at p<0.05 (two-
tailed).  
 
4.3 Results 
Descriptive statistics 
Table 4-1 shows the study population characteristics by sex and hypertension risk (N=838; 
48.0% boys).  Boys were heavier at birth and at ages 2 and 4 years and taller at 2, 4 and 18 years 
than girls.  Systolic blood pressure was significantly higher by 6 mmHg in boys than girls; on the 
contrary, girls had significantly higher DBP than boys at age 18 years.  There were no sex 
differences with respect to all SES measures, gestational age, being born small for gestational 
age, weight at age 18 years and MAP. 
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Overall, 14.8% of the participants in the study sample were hypertensive (n=124) and 49.1% of 
these were boys.  Participants who were hypertensive were significantly 5.5kg heavier at age 18 
years compared to their normotensive counterparts.  No major differences in hypertension risk 
with respect to SES change between infancy and adolescence, birth measures, weight and height 
in childhood and height at 18 years were observed.
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Table 4-1 Study characteristics in infancy and adolescence by sex and blood pressure status at age 18 years (n=838) 
 
 Variables All 
Boys 
 N (%) 
Girls  
N (%) 
P value 
Non-
Hypertensive  
N (%) 
Hypertensive  
N (%) 
P value 
Socio economic status  (Exposure)               
Household  SES change  between infancy and adolescence,%               
Low-low(ref) 255(30.4) 133(33.1) 122(28.0) 0.522 211(29.6) 44(17.3) 0.541 
Low-medium 97(11.6) 45(11.2) 52(11.9)   81(11.3) 16(12.9)   
Low-high 35(4.2) 17(4.2) 18(4.1)   34(4.8) 1(0.81)   
Medium-low 99(11.8) 41(10.2) 58(13.3)   85(11.9) 14(11.3)   
Medium-Medium 71(8.5) 32(8.0) 39(8.9)   61(8.5) 10(8.1)   
Medium-high 43(5.1) 25(6.2) 18(4.1)   38(5.3) 5(4.0)   
High-low 78(9.3) 39(9.7) 39(8.9)   67(9.4) 11(8.9)   
High-Medium 81(9.7) 37(9.2) 44(10.1)   67(9.4) 14(12.0)   
High-high 79(9.4) 33(8.2) 46(10.6)   70(9.8) 9(7.3)   
 Total 838  402(48.0) 436(52.0)    714(85.2) 124(14.8)    
Participant characteristics               
In childhood                
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Values are presented as mean (standard deviation) computed from a t-test for continuous variables or as N (%) for categorical variables obtained from a chi square test and Fischer’s exact for N<5. 
 
Gestational age, weeks (SD) 838 38(1.7) 38(1.8) 0.3736 38(1.7) 38(1.8) 0.8009 
Birth weight ,g (SD) 838 3.1(0.5) 3.0(0.5) <0.01 3.1(0.5) 3.1(0.5)   
Small-for-Gestational age(SGA),%               
No 743 348(86.6) 395(90.6) 0.066 639(89.5) 104(83.9) 0.068 
Yes 95 54(13.4) 41(9.4)   75(10.5) 20(16.1)   
Weight at age 2,kg (SD) 838 11.6(1.5) 11.3(1.4) 0.0177 11.4(1.4) 11.5(1.5) 0.5112 
Weight at age 4,kg(SD) 838 15.6(1.9) 15.2(2.0) <0.01 15.3(2.0) 15.6(2.0) 0.0884 
Height at age 2, cm(SD) 838 83.4(3.5) 82.5(3.2) <0.001 83.0(3.3) 82.8(3.5) 0.4768 
Height at age 4, cm(SD) 838 99.1(3.9) 98.6(3.8) 0.0309 98.8(3.9) 98.8(4.0) 0.854 
In Adolescence                
Age, years(SD) 838 17.8(0.4) 17.8(0.4) 0.4521 17.8(0.4) 17.8(0.4) 0.2287 
Weight at age 18, kg(SD) 838 59.8(10.2) 59.3(12.4) 0.6017 58.7(10.2) 64.2(15.5) <0.001 
Height at age 18,cm(SD) 838 170.6(8.2) 159.6(6.0) <0.001 165.1(8.8) 163.5(9.9) 0.0685 
Blood pressure measures at 18 years               
SBP, mmHg(SD) 838 121(10.6) 115(9.5) <0.001 115(8.5) 131(11.2) <0.001 
DBP, mmHg(SD) 838 71(8.5) 72(8.5) 0.0410 70(6.9) 81(11.0) <0.001 
MAP, mmHg(SD) 838 87(8.2) 87(8.4) 0.1525 85(6.3) 99(8.3) <0.001 
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Determinants of blood pressure and hypertension status 
In unadjusted analyses, SBP was significantly associated with change from low-to high SES 
between infancy and adolescence, sex, age, weight and height at 18 years, and relative weight 
gain independent of height at 0-2 and 4-18 years (Appendix 4). DBP was significantly associated 
with sex (higher in males), age and weight at age 18 years and weight gain from age 4 to 18 
years.  MAP was predicted by weight and height at 18 years, and weight gain from age 4 to 18 
years.   Hypertension risk was significantly associated with weight at 18 years and weight gain at 
ages 2-4 and 4 to 18 years. 
 
Association between SES change and blood pressure and hypertension status 
Multiple linear regression analyses of SES change characterized by nine subgroups and age-, 
sex- and height-adjusted SBP, DBP and MAP are presented in Table 4-2.  SES change from low 
to high tertile was significantly associated with 4.8 mm Hg lower SBP compared to those who 
maintained a low SES profile between infancy and adolescence, adjusted for SES in infancy, 
SGA and weight gain between infancy and adulthood.   The associations between DBP and 
MAP, and SES change were statistically insignificant in all the models.  
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Table 4-2Multiple regression models for the relationship between SES change and SBP, DBP and MAP at 18 years of age in 
Urban Black South Africans 
Blood pressure measure SBP DBP MAP 
  Model 1(n=838) Model 2(n=838) Model 1(n=838) Model 2(n=838) Model 1(n=838) Model 2(n=838) 
Covariates Β 95%CI P value β 95%CI 
P 
value 
β 95%CI 
P 
value 
β 95%CI P value β 95%CI 
P 
value 
β 95%CI P value 
SES change 
                  
Low-low(ref) 
                  
Low-medium -0.74 -3.08 to1.60 0.532 -0.38 -2.63 to 1.86 0.737 -0.52 -2.52 to 1.48 0.608 -0.33 -2.32 to 1.66 0.743 -0.62 -2.56 to1.33 0.532 -0.34 -2.24 to 1.55 0.723 
Low-high -5.10 -8.61 to-1.58 <0.01 -4.85 -8.22 to -1.48 <0.01 -2.41 -5.42 to 0.60 0.117 -2.27 -5.25 to 0.71 0.136 -2.99 -5.91 to 0.07 0.045 -2.81 -5.66 to 0.03 0.053 
Medium-low -0.52 -3.52 to 2.48 0.735 -0.69 -3.57 to 2.19 0.639 1.20 -1.37 to 3.77 0.358 1.09 -1.45 to 3.64 0.398 0.44 -2.05 to 2.94 0.725 0.34 -2.09 to 2.77 0.782 
Medium-Medium -1.77 -5.01 to1.48 0.285 -2.23 -5.35 to 0.89 0.16 -0.13 -2.91 to 2.64 0.925 -0.34 -3.10 to 2.42 0.811 -1.19 -3.88 to 1.51 0.388 -1.44 -4.07 to 1.19 0.282 
Medium-high -0.90 -4.64 to 2.83 0.634 -1.07 -4.66 to 2.51 0.557 -0.02 -3.22 to 3.18 0.99 -0.15 -3.33 to 3.02 0.925 -0.51 -3.61 to 2.60 0.749 -0.60 -3.63 to 2.43 0.696 
High-low -3.65 -7.79 to 0.48 0.083 -3.93 -7.90 to 0.04 0.062 -1.20 -4.74 to 2.34 0.505 -1.39 -4.90 to 2.13 0.439 -1.81 -5.24 to 1.62 0.302 -1.98 -5.33 to 1.37 0.247 
High-Medium -1.38 -5.50 to 2.73 0.51 -2.03 -5.98 to 1.91 0.312 1.36 -2.16 to 4.88 0.448 1.03 -2.45 to 4.53 0.56 0.39 -3.02 to 3.81 0.821 -0.60 -3.39 to 3.27 0.972 
High-high -3.47 -7.84 to 0.90 0.12 -3.41 -7.60 to 0.78 0.34 0.03 -3.71 to 3.77 0.989 0.00 -3.71 to 3.71 1.000 -1.41 -5.04 to 2.23 0.448 -1.35 -4.89 to 2.19 0.456 
Sex -4.03 -5.86 to -2.20 <0.001 -4.2 -5.98 to -2.42 <0.001 1.94 0.38 to 3.51 0.015 1.78 0.21 to 3.37 0.026 0.54 -0.98 to 2.06 0.486 0.47 -1.04 to 1.97 0.544 
Participant age, years 2.49 0.69 to 4.30 <0.01 2.42 0.69 to 4.14 <0.01 -1.30 -2.84 to 0.25 0.1 -1.32 -2.85 to 0.21 0.092 -0.08 -1.58 to 1.43  0.921 -0.14 -1.60 to 1.32 0.853 
Participant height, cm 0.17 0.06 to 0.28 <0.01 0.18 0.08 to 0.29 <0.01 0.07 -0.02 to 0.16 0.132 0.07 -0.02 to 0.16 0.131 0.12 0.02 to 0.21 <0.01 0.13 0.04 to 0.22 <0.01 
Household SES in infancy   0.55 -0.46 to 1.55 0.285 0.64 -0.32 to 1.60 0.192 -0.15 -1.01 to 0.70 0.726 -0.10 -0.95 to 0.75 0.818 0.10 -0.73 to 0.93 0.821 0.17 -0.64 to 0.98 0.683 
Small-for-Gestational age 
   
0.87 -1.22 to 2.96 0.415 
 
 
 
-0.16 -2.01 to 1.69 0.866 
   
0.51 -1.25 to 2.28 0.571 
Relative weight gain (0-2years) 
   
1.06 0.38 to 1.74 <0.01 
 
 
 
0.49 -0.12 to 1.09 0.114 
   
0.65 0.07 to 1.22 0.028 
Relative weight gain (2-4years) 
   
0.65 0.02 to 1.27 0.044 
 
 
 
0.29 -0.26 to 0.85 0.300 
   
0.62 0.08 to 1.15 0.023 
Relative weight gain (4-18years) 
   
2.79 2.12 to 3.47 <0.001 
   
1.28 0.68 to 1.87 <0.001 
   
1.85 1.28 to 2.42 <0.001 
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Adjusted R² value 0.1053 0.1804 0.0064 0.0260 0.0076 0.0605 
¹Model 1: adjusted for sex, current height, age, and household SES in infancy. 
²Model 2: Model 1 + growth (SGA, relative weight gain in infancy and mid-childhood)³Baseline BP : SBP at 5 for SBP, DBP at 5 for the DBP and MAP at 5 for the MAP models, accordingly 
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Adjusted logistic regression models (Table 4-3) show no significant association between SES 
change from the low-high category and hypertension risk.  Relative weight gain at 2-4 and 4-18 
years predicted 30% and 66% increased odds of hypertension independent of SES change, SES 
in infancy, SGA and relative weight gain in infancy.   
 
Table 4-3 Adjusted odds ratios of being hypertensive at 18 years in urban black South 
African children (n=838) 
  Model 1 Model 2 
Covariates OR 95%CI 
P 
value OR 95%CI P Value 
SES change between infancy and adolescence       
Low-low(ref) 1  
 
1 
  Low-medium 0.92 0.48 to 1.72 0.787 0.99 0.51 to 1.88 0.968 
Low-high 0.14 0.02 to 1.04 0.055 0.14 0.02 to 1.04 0.055 
Medium-low 0.61 0.27 to 1.42 0.255 0.57 0.24 to 1.34 0.197 
Medium-Medium 0.61 0.25 to 1.52 0.290 0.53 0.21 to 1.36 0.186 
Medium-high 0.49 0.16 to 1.50 0.213 0.47 0.15 to 1.48 0.198 
High-low 0.51 0.16 to 1.64 0.259 0.46 0.14 to 1.56 0.214 
High-Medium 0.65 0.21 to 2.02 0.455 0.51 0.16 to 1.65 0.262 
High-high 0.38 0.11 to 1.37 0.140 0.36 0.10 to 1.33 0.125 
Household SES in infancy  1.14 0.86 to 1.52 0.359 1.20 0.89 to 1.61 0.237 
Small-for-Gestational age(SGA),%    1.33 0.75 to 2.33 0.328 
Relative weight gain (0-2years)    1.18 0.96 to 1.45 0.119 
Relative weight gain (2-4years)    1.31 1.08 to 1.58 <0.01 
Relative weight gain (4 to18years)    1.65 1.35 to 2.04 <0.001 
Pseudo R² value 0.0135 0.0630 
Model 1 adjusted for SES at baseline,  
Model 2 model 1 +growth (SGA, relative weight gain in infancy  and mi-childhood)  
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Furthermore, additional multivariate analyses of factors associated with blood pressure and 
hypertension risk in urban South African black participants aged 18 years are presented in 
Appendix 5. In these associations adjusting for alcohol intake and baseline blood pressure did 
not significantly alter the variance explained by the models. 
 
4.4 Discussion 
Main findings  
We found that an upward mobility in SES was strongly associated with lower SBP at 18 years of 
age in contrast to remaining in a low SES profile between infancy and adolescence. This study 
highlights that the association between an upward social mobility and reduced SBP is not fully 
explained by growth trajectories in relative weight since the association remained significant 
even after controlling for growth.  There was no association between SES change and DBP, 
MAP and hypertension risk. 
 
Comparison with other studies 
Our results are consistent with previous studies which reported that upward social mobility is 
related to reduced blood pressure.  The Pitt county study of African American men aged 25 to 50 
years at baseline in 1988 by James et al (147) reported that compared to the stable low SES 
group between childhood and adulthood, upward SES mobility between childhood and adulthood 
was associated with 47% reduction in hypertension risk using education, occupation and 
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employment status to compute life course SES.  Childhood SES data were collected 
retrospectively in this study thereby compromising internal validity of the findings.  The Swedish 
study of twins born between 1926 and 1958 reported 16% lower odds in the upwardly mobile 
SES group compared to the stable low SES group independent of familial factors.(144)   This 
study used intergenerational SES measures based on parental and the offspring occupation as a 
measure for life course SES and self-reported hypertension status which is prone to information 
bias.  
 
Contrary to our findings, a USA study conducted between 2002 and 2003 reported that children 
who experience an upward mobility trajectory in SES between 14 to 18 years of age had higher 
SBP compared to those who remained in the low SES profile. However, the results might have 
been influenced by the under-representation of low SES children in their study. (142) Hallal et 
al, (146) found no association between socioeconomic trajectories from birth to 11 years of age 
and SBP and DBP in 15 year old Brazilian adolescents born in 1993 using household income as 
an indicator of SES. 
 
 Possible explanation of the findings 
Being small for gestational age had no independent effect on the association between SES 
change and SBP at 18 years implying that postnatal growth might be more important for 
programming of social gradients in blood pressure than prenatal growth. Social mobility effects 
on SBP are not fully explained by growth implying that a dynamic SES environment may 
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influence blood pressure through additional mechanisms.  Potential mechanisms through which 
an upward mobility in SES reduces blood pressure have been evaluated; including bio-behavioral 
factors and chronic stress. (227) An upward mobility in social class might imply that adolescents 
are protected from negative health behavior associated with poor households such as poor diet, 
lower levels of physical activity, and higher prevalence of tobacco smoking or alcohol intake.  
However, in this study, adding alcohol use to the models did not alter the associations.  
 
Association between SES change and blood pressure was significant for SBP but not DBP, 
implying that SBP might be more sensitive to environmental factors compared to DBP.  
Persistent low SES is a chronic stressor which is related to an increase in sympathetic nervous 
system reactivity and changes in vasculature which raises SBP.(228)   High SBP may be an 
indicator of vascular dysfunction as a result of progressive stiffening of arterial walls or changes 
in the vasculature and it has been reported to be a stronger predictor of hypertension and 
cardiovascular diseases than DBP.(229)  
 
Sex had a distinct independent relationship with SBP, DBP and hypertension risk.   However, 
when the analyses were stratified by sex, the associations remained significant for boys only in 
the SES change-SBP models only, implying that the protective effect of upward social mobility 
may be apparent in boys and not girls but this needs to be further explored with a larger sample 
size (Appendix 6). 
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Strengths and limitations 
These findings were based on a prospective birth cohort, thereby minimizing recall bias and 
having the potential to establish a causal relationship between life course SES and blood 
pressure. Asset based-SES measures are more sensitive measures for SES compared to education 
and employment in LMICs since using schooling years for education might not take into account 
repeated years (230), employment can be informal and transitory,  and income and expenditure 
are notoriously difficult to assess without extensive validation from secondary sources (231).  
 
In contrast to previous studies on social mobility and hypertension which used self-reported 
measures of hypertension, we employed an objective measurement of blood pressure by trained 
research assistants.  Furthermore, the study used both sexes in black urban South African 
adolescents from a rapidly transitioning urban environment which can be generalized to other 
African societies in transition. Sex, age and height adjusted  blood pressure measures were used 
in the multivariate models since blood pressure in children and adolescents varies according to 
age, height and sex (232).  Unlike other studies, we adjusted for covariates to disentangle the 
effect of early life SES and weight gain on the SES change-BP relationship hence increasing the 
potential to infer causality.  
 
There are a number of considerations that may pose as limitations.  Firstly, we could not include 
other ethnic groups due to under-representation in the low SES group at the two time points; 
hence our findings may not be generalizable to the entire South African population.  The 
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proportion of hypertensive participants who were in the low-high SES change category was low 
and this might have resulted in underestimation of the upward social mobility-hypertension risk 
association resulting in marginal associations.  Alcohol intake and tobacco use were self-reported 
hence we do not rule out reporting bias.  There was potential for selection bias in the analytical 
sample, however, there were no significant differences between the black participants included 
and those excluded from the study with regards to the key study variables thereby increasing the 
potential to generalize these findings.  
 
4.5 Conclusions  
Our study adds to a limited body of evidence concerning the protective effect of upward social 
mobility on blood pressure and shows an association between SES change in the early life-course 
from birth to adolescence and SBP in early adulthood. There is a need for replication of this 
study to assess its generalizability in other geographical settings and other ethnic groups. These 
study findings imply that national social and economic policies introduced in the post-apartheid 
era which seek to improve quality of life among previously disadvantaged black populations 
have the potential to reduce cardiovascular disease burden attributed to high blood pressure.  
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5 CHAPTER 5:  ASSOCIATION BETWEEN EARLY LIFE GROWTH AND 
BLOOD PRESSURE TRAJECTORIES IN BLACK SOUTH AFRICAN 
CHILDREN 
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Pettifor , PhD, Shane A. Norris, PhD. 
(Published in Hypertension: 2016;68(5):1123-31)(233) 
 
5.1 Introduction 
Hypertension remains a major cause of morbidity and premature mortality, and a leading risk 
factor for the global burden disease worldwide (234). High blood pressure (BP) in adulthood will 
affect three quarters of the population in low and middle income countries (LMICs) by 2025 (8). 
Of great concern is the emergence of hypertension in pediatric populations concomitant with the 
rising epidemic of obesity(116). We recently showed that BP tracks from early childhood to late 
adolescence in a black South African population; one in three children with elevated BP at age 5 
years (>90
th
 percentile for age, height and sex) remain so at age 18 years (188),  Since children 
with elevated BP may show early signs of cardiovascular damage, renal injury and are likely to 
have high BP in adulthood (130, 235), identifying children with atypical BP patterns and risk 
factors may be crucial for early life intervention to modify progression to hypertension in 
adulthood.  
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Substantial evidence suggests that early life growth predicts elevated BP, particularly in children 
who are small at birth but experience accelerated growth in childhood (5, 34, 236). Conventional 
growth modelling techniques have been used to explore how early life growth relates to mean 
levels or changes in BP in children and adolescents. Those studies use a single mean growth 
curve to describe BP trajectories in a given population and assume that covariates influence the 
growth curve in a similar way (237).  Yet BP is a highly variable physiological characteristic, 
hence describing a population using a single estimated trajectory oversimplifies the complexity 
of BP tracking patterns that characterize children and adolescents.  In addition, height is a known 
marker of early life environment and a major correlate of BP in childhood and adolescence 
(238), and thus should be incorporated in longitudinal modelling of BP. 
 
Recently, investigators have begun to use finite mixture models to identify distinct clusters of 
individuals following similar patterns of BP change over time (176, 239).  One recent study 
identified four SBP trajectory groups between ages 7 and 38 years using group-based trajectory 
modeling (GBTM) on data from the Dunedin longitudinal birth cohort. That study reported that 
low birth weight was associated with higher odds of being in the hypertensive trajectory group 
(240). In support of those findings, a UK birth cohort reported two to three BP trajectory groups 
in midlife (36 to 53 years) and confirmed that individuals with higher birth weight were likely to 
be in the normative BP group  than in the ‘BP increaser’ groups (161). Trajectories of BP in 
black children and adolescents in South Africa have not been identified, and are complicated by 
more ambiguous definitions of elevated BP in children than in adults. GBTM may be useful in 
identifying children with atypical patterns of SBP and DBP and their associated risk factors. 
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To our knowledge, no study in Africa within a LMIC scenario has explored the association 
between early life growth and trajectories of BP in children and adolescents, which is likely to be 
important because of the increasing burden of hypertension on this continent.  We hypothesized 
that early growth, in particular lower birth weight and rapid postnatal weight gain is associated 
with a higher height-adjusted BP trajectory in a Black South African pediatric population.  The 
aim of this study was to use Birth to Twenty longitudinal birth cohort data (Bt20) to (1) identify 
distinct trajectory groups for BP between 5 and 18 years of birth, (2) examine the association 
between early growth and BP trajectories and (3) assess the influence of height on the 
association between early growth and BP trajectories.  
 
5.2 Methods 
5.2.1 Study population 
The data analyzed here are from the Bt20 cohort study of singleton children born within a 7-
week period in Soweto, Johannesburg in 1990 (n=3273).  Details of recruitment and selection 
criteria for the cohost study are described elsewhere (183). All parents and caregivers of the 
children provided written informed consent, and the University of Witwatersrand Committee 
granted ethical approval for Research on Human Subjects (certificate number:  M130556).  The 
study sample was restricted to black participants (approximately 78% of the cohort), who had not 
been pregnant during adolescence and had anthropometric measurements, SBP and DBP 
measurements at two or more of the following mean ages:  5years (n=1046;49.0% boys), 8years 
(1175;48.8%), 10years (n=695;48.6%), 13years (n=1355;47.5%), 14years (n=1392;47.4%), 
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16years (n=1657;48.1%) and 18years (n=1592;48.2%) .  The overall sample size was n=1937 
(1005 girls and 932 boys).  
 
5.2.2 Assessment of blood pressure 
BP was measured in a seated position in triplicate: after a five minute rest and a two minute 
interval between measurements, using Dinamap Signs monitor 1846SX (Critikon, USA) at 
5years and an Omron M6 (Omron, Kyoto, Japan) at 8 to 18years.  All the measurements were 
taken by a trained research assistant using an appropriate cuff size.  Hypertension status at age 5 
years was classified as greater than 95
th
 percentile for age, sex and height using the Fourth report 
on National High Blood pressure program in children and adolescence (47). 
 
5.2.3 Assessment of growth 
Birth weight and gestational age were obtained from birth notification records entered at birth. 
Subsequently, weight was measured using a digital scale to the nearest 0.1kg and height was 
measured using a calibrated stadiometer.  Birth weight, weight-for-age and height-for-age z-
scores were computed using WHO growth standards (241). To deal with high correlation of 
repeated weight and height measures in longitudinal data, conditional weight independent of 
height (relative weight gain) and  relative height gain independent of weight (relative linear 
growth) were computed as standardized residuals derived from sex-specific linear regressions of 
a current growth measure on a prior one in infancy (0-2years) and mid-childhood (2-5 years) 
(226, 242). 
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5.2.4 Assessment of covariates 
Maternal and infant characteristics at birth were identified using standard questionnaires. Socio-
economic status (SES) in infancy was represented as a count of household assets reported by the 
mother or caregiver. 
 
5.2.5 Statistical analysis 
Group based trajectory modeling (GBTM) was performed using a STATA plug in program of 
SAS Proc Traj to estimate model parameters using maximum likelihood estimation in STATA 
11(243).  We used a censored normal model for continuous variables, firstly without covariates, 
then including height as a time varying covariate (preliminary analyses). To identify the groups, 
two-class models were specified for SBP and DBP for each sex, then classes were added 
sequentially until parsimony was attained for linear, quadratic and cubic terms (Table S1). To 
test the model with the best fit we used the following criteria: low Bayesian Information 
Criterion (BIC), high posterior probabilities (above 0.7), not less than 1% of total sample in a 
trajectory group and prior knowledge from the literature (174). Thereafter, the groups defined 
from the best-fitting models were used as categorical outcome variables in  multinomial logistic 
regression models with covariates (time varying and time invariant) yielding the log-odds 
estimates, standard errors and p values, from which odd ratios and 95% confidence intervals 
(95% CI) were computed. 
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 Not all participants had measures at all occasions; hence we compared those who were included 
in the sample and those with missing BP measures with respect to key variables to inform 
whether missingness was random (Table S2).  Descriptive statistics were conducted to 
characterize average BP per occasion by BP class membership. ANOVA was used to describe 
continuous study sample characteristics for each BP trajectory and to validate the trajectory 
groups using BP status at age 5 years of age and ϰ² test was used for categorical study variables.  
Multinomial logistic regressions were conducted in traj and the estimates and standard errors 
converted to odds ratios and 95% confidence intervals 
 
5.3 Results  
1005 girls and 932 boys had BP measurements on at least two occasions. There were no 
significant differences between the analyzed sample and those not included (n=631) with regards 
to birth weight, weight in infancy and mid-childhood, height in infancy and childhood, but the 
two samples differed with regards to SES in infancy. Those in the included sample had lower 
number of household assets compared to those excluded (p<0.0001). 
 
In each sex, the best-fitting models included three distinct trajectories for SBP and DBP with 
cubic terms (Table S1). For descriptive purposes, the BP trajectories were labelled as ‘lower’, 
‘middle’ or ‘upper’. The lower trajectory was considered as the reference group in all regression 
analyses (Figure 1 and 2). The BP trajectories represent mean BP based on the posterior 
probabilities of being assigned to a particular class.  In boys (Figure 1 A-D), the upper SBP 
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trajectory group (16.4%) started at 125.0mmHg at age 5 years and increased to 132.4mmHg by 
age 18 years.  The middle SBP trajectory group (55.3%) started at 107.3mmHg and increased to 
122.9mmHg.  The lower SBP trajectory group (28.2%) started at 101.9mmHg and increased to 
115.2 mmHg.  In girls (figure 2A-D), the upper SBP trajectory group (13.6%) started at 120.5 
mmHg and increased to 125.7mmHg, the middle SBP group (53.2%) started at 110.4mmHg and 
increased to 116.9mmHg; and the lower SBP group (33.2%) started at 99.0mmHg and increased 
to 107.5mmHg (Table 1).  
 
Adding child’s height between 5 and 18 years as a time varying covariate reduced by half the 
proportion of individuals in the upper SBP trajectory in both boys (7.1%) and girls (7.5%) 
(Figure 1B and 2 B) but made no major differences for DBP (Figure 1D and 2D). Table S3 
describes the association of age terms and height, and BP trajectories for the time varying 
models.  Height between ages 5 and 18 was positively associated with all BP trajectories in boys 
and girls, except an apparent protective effect on the upper SBP trajectory in girls (est:-0.25, SE: 
0.10, p=0.0125). The DBP trajectory for girls was not associated with height between ages 5 and 
18. 
 
Hypertension status at age 5 years was highly predictive of height-adjusted BP trajectory (Table 
S4). The relative risk of being in the upper and middle SBP trajectory given a BP status above 
the 95
th
 percentile for age sex and height was 3.85 and 21.80 times higher compared to the lower 
trajectory in boys. In girls, the relative risk ratios were almost six and seven fold greater for the 
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middle and upper relative to the lower SBP trajectory for a BP measure above the 95
th
 percentile 
for age, height and sex. With respect to DBP trajectories, BP status at age 5 years was highly 
predictive of the BP trajectory groups with higher risk for the upper and middle trajectory groups 
compared to the lower one in both sexes.  
 
SBP trajectory group membership in boys was associated with relative linear growth in infancy 
and childhood, and SES in infancy, while in girls it was associated with relative weight and 
relative height gain in infancy and childhood, parity, maternal age and household assets in 
infancy and SBP at age 5 years. With respect to DBP, rapid relative weight gain in infancy, rapid 
linear growth in mid-childhood, DBP at age 5 years and SES in infancy was significantly 
associated with the girls’ trajectory group membership (Table 2). For the height-adjusted BP 
trajectories, weight gain in infancy and childhood, parity, BP at 5 years of age and SES between 
0-2 years of age remained as determinants of class membership for the girls, while in boys, 
relative linear growth in mid-childhood and BP at age 5 years were associated with BP trajectory 
groups. 
 
Relative weight gain in infancy and rapid linear growth between birth and mid-childhood was 
associated with SBP trajectory group membership in boys after adjusting for time invariant 
covariates (Table 3). However, in height-adjusted models, a unit increase in birth weight reduced 
the risk of being in the middle trajectory by 25% (OR: 0.75; 95%CI 0.58-0.96, p=0.0223) while 
rapid weight gain in infancy was associated with almost a 4-fold higher risk (OR: 4.11; 1.25-
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13.51; p=0.0202) of being in the upper trajectory. In girls, relative weight gain and linear growth 
in infancy were associated with higher odds of being in the middle and upper relative to the 
lower SBP trajectory in height-adjusted models. 
 
Rapid weight gain in infancy and mid-childhood and linear growth were associated with higher 
odds of being in the middle versus lower DBP trajectory (Table 4).  However, in height-adjusted 
models, an association only remained for relative weight gain in infancy (OR: 1.43; 1.06-1.95; 
p=0.0214).  The upper versus lower DBP trajectory group in boys was positively associated with 
relative weight gain in infancy and linear growth in mid-childhood, but these associations were 
diminished or reversed in height-adjusted models, leaving linear growth in infancy as the only 
significant predictor of upper versus lower DBP trajectory (OR: 0.47; 0.29-0.76; p=0.0021). In 
girls, relative weight gain and linear growth in mid-childhood were positively associated with 
being in the middle versus lower DBP trajectory, while weight gain in infancy was a predictor of 
upper vs lower DBP trajectory  (OR: 2.53; 1.14-5.57; p=0.0219). 
 
5.4 Discussion  
Using GBTM, we identified three sex-specific trajectories for SBP and DBP; each showing 
gradual increases in BP with age in Black South African children.  In boys, upper and middle BP 
height-adjusted trajectory membership was inversely associated with birth weight and positively 
associated with relative weight gain and linear growth in infancy. Girls who experienced 
accelerated growth (both in weight and height) in infancy and childhood tended to be in the 
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upper vs lower SBP trajectory, while rapid growth in infancy positively predicted being in the 
middle vs lower class. With regard to DBP in girls, rapid relative weight gain in infancy and 
mid-childhood were predictors for the upper and middle trajectories (in comparison to the lower 
trajectory).  These findings support the hypothesis that accelerated relative weight gain in early 
life may program higher long-term disease risks (244). 
 
A major feature of our study is that we confirmed heterogeneity in BP over time in children and 
adolescents by reporting three latent classes for SBP and DBP for each sex. Previous 
longitudinal cohort data analyses of BP trajectories focused on adult populations (245, 246) or 
growth curve modelling using one BP trajectory (154). Consistent with the findings from the 
Framingham Heart study of 1060 males aged 25+ with longitudinal BP measurements at four 
time points, we identified three trajectory classes for SBP and DBP(176).  However, other 
studies found different numbers of classes, including a UK study which reported 2 classes each 
for SBP and DBP in midlife in men (161). The CARDIA cohort in USA examined adults aged 
18 to 30 years at baseline and reported five distinct trajectories of mid-BP (mean of SBP and 
DBP). However, this study did not disentangle the age-related changes in SBP and DBP, which 
are physiologically distinct measures (166).   
 
In the present study, height between 5 and 18 years of age was closely associated with trajectory 
groups, except for the girls’ upper SBP and DBP trajectories. These findings might imply that 
stature may have a greater impact on BP in boys than girls. With regards to sex differences, a 
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study of BP trajectories in a Caribbean adolescent population aged 11 to 18 years reported that 
rate of change of both SBP and DBP was greater in boys than in girls (162). Sex discrepancies in 
BP trajectories and their associations with early growth might be attributed to influence of 
androgens on the regulation of long term BP in response to early environmental factors (247). 
Although the specific mechanisms underpinning sex differences in the programming of life 
course BP are not fully known, testosterone is reportedly positively associated with renin 
angiotensin activation and oxidative stress, which in turn contribute to elevated BP differently in 
males (86) and females (87).  
 
This study confirms that BP increases with age and height between ages 5 and 18 years, except 
in the upper BP trajectories for girls. Unlike in adults, height is a recognized major determinant 
of childhood BP and is routinely considered to evaluate childhood BP centiles and hypertension 
status (46).  Childhood height is an indicator of growth of the arterial tree, which influences 
hemodynamic BP control mechanisms especially vasculature structure and function (248). These 
findings are consistent with a number of cross sectional studies(249) and confirm the importance 
of inclusion of age and height in the definition of elevated BP in children and adolescents. Since 
there are physiologic increases in childhood BP with height, it is important to consider the effect 
of height as a covariate when identifying trajectory groups, so as to avoid simply categorizing 
tall children with normal BP for their height.  
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For height-adjusted BP trajectories, the association between infant and mid-childhood linear 
growth and BP, especially for boys and for DBP, implies that change in BP may be more 
susceptible to later stature in boys than girls. In support of the fetal origins hypothesis, we 
reported that higher birth weight was associated with lower odds of being in the middle versus 
the lower boys’ SBP trajectory in the final models. This finding may indicate that children who 
are born low weight but who go on to increase their stature after mid-childhood may be at risk of 
having moderately increasing BP. 
 
In support of the growing evidence on BP tracking in childhood (128), we have shown that 
hypertensive status at age 5 years was highly predictive of BP trajectory between 5-18 years.  
This finding validates the importance of early detection through routine BP screening in 
childhood to identify children who are most likely to follow elevated BP trajectories over their 
life course. Early onset of elevated BP may indicate that physiological mechanisms influencing 
variation in BP and risk of elevated BP might start in early life and may amplify with age in 
response to genetic and environmental factors.  
 
A major strength of this study is its prospective nature.  In addition, there were no major 
differences between those children excluded from the study and the analytical sample with 
regards to key study characteristics and any differences were adjusted in the multivariate models. 
We employed GBTM to identify sex-specific BP trajectories. This is an extension of traditional 
growth modelling which takes into account time varying and invariant covariates in 
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characterizing the change in BP over time and heterogeneity within BP data. GBTM is suitable 
for examining physiological traits like BP which are highly variable in children and adolescents 
and provides better model fit and parsimony compared to linear mixed models (174). However, 
inferences regarding latent class membership and their association with relative weight gain in 
early life might not extend to the entire South African population since the analyses were 
confined to the black ethnic sample. Use of ambulatory blood pressure monitoring measure may 
provide more insight into BP trajectories compared to an average BP measurement on one 
occasion.  Future research studies need to replicate group based trajectory modeling in other 
cohort studies using other time varying covariates like physical activity and dietary patterns. 
 
In the context of an emerging epidemic of hypertension in black LMIC populations, this study 
suggests that BP trajectories may be set early in childhood, with BP in early childhood BP highly 
predictive of BP trajectories.  Early life growth, in particular high relative weight gain, may be a 
crucial target for interventions to interrupt elevated BP trajectories and to prevent the early onset 
of raised BP. Further research needs to identify individuals in the middle and upper trajectories, 
to assess other cardiovascular disease indicators such as left ventricular hypertrophy, arterial 
stiffness, and to consider appropriate interventions in early life to interrupt the trajectories and 
benefit long-term health. 
5.4.1 Perspectives 
In summary, this study highlights the potential for early interventions aimed at optimizing 
growth in early life may play an important role in prevention of elevated BP progression in 
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children and adolescents. This calls for a concerted effort among global healthcare practitioners, 
researchers, and other related organizations to prioritize pediatric hypertension on the global 
health agenda especially in Low to Middle Income countries (LMICs) where the burden of 
disease attributed to hypertension is already high in midlife and exerting pressure on the health 
care system. Future research needs to explore the clinical relevance of the elevated BP 
trajectories, the key risk factors and progression to and hypertension and cardiovascular disease 
in adulthood. 
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Novelty and Significance 
What is new? 
 This is the first study to show distinct BP trajectories from early childhood to late 
adolescence in African children 
 Rapid early growth predicts higher longitudinal BP trajectories in childhood  
What is relevant? 
 Age related changes in SBP in children and adolescents are height dependent hence 
longitudinal profiles of paediatric BP should account for stature.  
Summary 
 Distinct trajectories of age-, sex- and height- dependent BP are detectable in children 
from 5 years of age. Rapid growth (both in weight and linear) in infancy and mid-
childhood predict the progression of BP between mid-childhood and late adolescence 
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Figures 
 
Figure 5-1 Trajectories of blood pressure for boys between 5 and 18 years of age.  
A. Systolic blood pressure over time. B. Systolic blood pressure over time adjusted for height as 
a time varying covariate. C. Diastolic blood pressure over time. D. Diastolic blood pressure over 
time accounting for height per time point 
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Figure 5-2 Girls trajectories of blood pressure between 5 and 18 years of age 
 A. Systolic blood pressure changes with age. B. Systolic blood pressure over time adjusted for 
height at each time point. C. Diastolic blood pressure over time. D. Diastolic blood pressure over 
time accounting for height per time point. 
117 
 
 
Table 1 Sex -specific Mean BP by trajectory group membership 
Mean Age(years) SBP trajectory group membership DBP trajectory group membership 
 Boys Girls Boys Girls 
 Low Middle Upper Low Middle Upper Low Middle Upper Low Middle Upper 
5   101.9(10.8) 107.3(10.4) 125.0(12.0) 99.0(8.6) 110.4(9.9) 120.5(13.3) 60.5(7.5) 65.8(7.8) 69.9(8.3) 60.5(6.9) 67.2(8.7) 70.0(8.6) 
8 101.7(7.5) 110.8(8.6) 119.0(10.9) 101.7(7.0) 110.3(8.4) 125.5(10.0) 65.9(7.0) 73.1(7.5) 75.1(6.8) 66.1(7.0) 73.8(7.5) 85.6(12.0) 
10 98.5(9.1) 106.8(9.4) 117.9(14.7) 99.1(8.5) 107.0(9.6) 119.2(13.2) 63.8(7.4) 69.7(7.8) 76.4(12.0) 64.2(7.5) 71.0(7.5) 80.3(12.8) 
13 96.9(6.7) 107.2(6.6) 119.1(9.2) 98.0(6.6) 107.5(6.9) 119.3(8.8) 61.0(5.9) 69.7(6.4) 80.6(11.5) 62.8(5.7) 72.3(6.6) 83.3(7.4) 
14 98.6(6.9) 109.1(7.3) 122.6(9.9) 99.0(6.8) 108.5(7.5) 120.3(9.7) 63.0(5.9) 72.7(6.7) 86.7(8.5) 65.1(5.9) 75.1(6.9) 91.0(7.2) 
16 105.3(8.0) 117.3(9.0) 132.3(11.3) 100.0(8.3) 112.7(9.1) 124.1(10.6) 62.8(6.4) 72.3(1.1) 90.9(13.1) 62.9(6.7) 73.2(7.3) 93.4(12.6) 
18 111.4(7.6) 122.9(8.2) 132.4(10.4) 107.5(7.0) 116.9(8.1) 125.7(9.2) 66.8(6.4) 75.3(7.2) 88.1(7.8) 67.2(6.2) 76.6(6.9) 97.5(12.2) 
 SBP trajectory group membership-height adjusted DBP trajectory group membership-height adjusted 
5 103.7(10.4) 110.7(12.0) 130.9(10.4) 100.6(9.1) 113.6(10.9) 113.1(13.6) 61.4(7.8) 64.9(8.1) 76.7(9.8) 60.4(7.0) 70.0(8.2) 70.0(8.2) 
8 104.7(8.3) 113.7(9.5) 118.0(10.3) 102.9(7.4) 113.2(9.2) 126.9(11.0) 66.7(7.2) 73.6(7.8) 73.9(5.1) 66.1(6.9) 85.3(11.0) 85.3(11.0) 
10 101.4(9.8) 109.6(10.9) 117.8(15.3) 100.0(8.4) 110.0(10.2) 118.9(17.3) 64.2(7.5) 70.3(8.1) 76.1(10.6) 63.8(7.4) 80.4(11.3) 80.4(11.3) 
13 100.6(7.8) 110.0(7.9) 121.0(10.9) 100.0(7.0) 109.1(7.4) 122.8(9.9) 61.6(6.0) 70.6(6.9) 80.8(13.4) 62.7(5.7) 84.0(7.1) 84.0(7.1) 
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14 102.2(7.9) 112.2(8.5) 128.2(10.4) 100.3(7.2) 110.3(7.3) 124.9(9.9) 63.6(6.2) 73.5(7.0) 86.8(9.7) 65.0(5.9) 89.5(7.4) 89.5(7.4) 
16 109.1(9.1) 121.2(9.9) 137.2(12.5) 102.0(8.8) 114.7(9.1) 128.0(11.6) 63.5(6.7) 72.9(7.9) 96.3(11.9) 62.6(6.5) 91.2(12.2) 91.2(12.2) 
18 115.2(8.9) 125.7(8.3) 134.0(13.5) 109.2(7.4) 118.3(7.7) 130.4(11.9) 67.2(6.4) 76.5(7.7) 87.4(7.9) 67.0(6.1) 96.0(11.8) 96.0(11.8) 
*Summary statistics showing mean blood pressure and standard deviations across the trajectory group memberships of blood pressure between ages 5 and 18 on seven time points depicted by mean ages. 
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Table 2 Study sample characteristics by sex and BP trajectory groups 
Study characteristics SBP trajectory group DBP trajectory group 
 Boys Girls Boys Girls 
 Lower Middle Upper Lower Middle Upper Lower Middle Upper Lower Middle Upper 
Gestational age(weeks) 38.0(1.5) 37.9(1.9) 38.0(2.0) 37.9(1.8) 38.0(1.8) 37.8(1.9) 37.9(1.9) 38.0(1.6) 37.8(2.9) 37.9(1.9) 37.9(1.6) 38.1(2.2) 
Birth weight(g) 3110.4(0.5) 3132.2(0.5) 3116.1(0.5) 3023.8(0.5) 3027.7(0.5) 3061.3(0.4) 3125.2(0.5) 3132.4(0.5) 3078.6(0.6) 3025.4(0.5) 3034.7(0.5) 3121.4(0.4) 
Relative weight gain infancy -0.05(0.9) 0.14(1.0) 0.17(1.0) -02(1.0) 0.20(1.0) 0.30(1.0)** 0.05(1.0) 0.17(1.0) 0.01(1.1) 0.07(1.0) 0.20(0.9) 0.78(0.8)* 
Relative weight gain mid-
childhood 
-0.14(1.0) 0.02(1.0) 0.07(1.2) -0.16(1.0) -0.08(1.0) 0.32(1.0)** -0.06(1.0) 0.04(1.1) 0-0.13(1.5) -0.14(1.1) 0.001(1.0) 0.44(1.0) 
Relative linear growth 
infancy 
-0.31(0.8) -0.05(1.0) 0.19(0.9)*** -0.31(0.9) 0.01(1.0) 0.14(1.0)*** -0.13(1.0) -0.03(1.0) 0.16(1.0) -0.12(1.0) -0.01(1.0) -0.31(1.2) 
Relative linear growth mid-
childhood 
-0.20(1.1) 0.04(1.0) 0.04(0.9)* -0.19(1.0) 0.03(1.0) 0.40(0.9)*** -0.13(1.0) 0.11(1.0) 0.30(1.1)* -0.07(1.0) 0.07(1.0) 0.64(1.0)* 
SBP at 5 years of age/mmHg 103.1(11.9) 108.4(11.1) 124.7(14.0)*** 104.0(1.4) 115.6(11.4) 118.7(16.0)*** -   -   
DBP at 5 years of age/mmHg -   -   60.2(7.7) 63.8(7.9) 71.7(7.9)*** 60.4(6.8) 66.7(8.7) 69.4(10.7)*** 
Parity:    ≤2 92(41.4) 298(33.8) 51(35.7) 149(48.5) 301(33.6) 40(33.6) 278(33.8) 156(39.5) 7(25.0) 304(36.7) 182(38.0) 4(28.6) 
>2 130(58.6) 583(66.1) 92(64.3) 158(51.5) 595(66.4) 79(66.4)*** 545(66.2) 239(60.5) 21(75.0) 525(63.3) 297(62.0) 10(71.4) 
SES in infancy(household 
assets) 
4(2) 3(2) 3(2)** 4(2) 3(2) 3(2)* 3(2) 3(2) 3(1) 3(2) 3(2) 3(1)** 
 SBP trajectory groups-height adjusted DBP trajectory groups-height adjusted 
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Gestational age 38.0(1.7) 37.9(2.0) 37.9(2.0) 37.9(1.8) 37.9(1.9) 37.9(1.5) 37.9(1.8) 38.0(1.7) 37.6(3.1) 37.8(2.0) 38.0(1.7) 38.0(2.1) 
Birth weight 3160.0(0.5) 3077.2(0.5) 3070.0(0.5) 3031.1(0.5) 3026.1(0.5) 3074.1(0.4) 3140.0(0.5) 3090.7(0.5) 3133.3(0.5) 3009.6(0.5) 3040.0(0.5) 3111.8(0.4) 
Relative weight gain infancy 0.11(1.0) 0.10(1.0) 0-0.02(1.1) -02(0.9) 0.25(1.0) 0.26(0.9)** 0.08(1.0) 0.15(1.0) 0-0.19(1.0) 0.02(1.0) 0.23(1.0) 0.81(0.8)*** 
Relative weight gain mid-
childhood 
0.01(1.1) 0-0.07(1.0) 0.03(1.2) -0.19(1.0) -0.02(1.0) 0.19(1.0)* -0.06(1.0) 0.07(1.1) 0-0.03(1.0) -0.17(1.1) 0.02(1.0) 0.44(1.0)* 
Relative linear growth 
infancy 
-0.09(0.9) -0.06(1.0) 0-0.33(0.9) -0.15(1.0) 0.01(1.0) 0-0.09(1.0) -0.04(1.0) -0.18(0.9) 0-0.04(1.0) -0.06(1.0) 0-0.06(1.0) -0.51(1.2) 
Relative linear growth mid-
childhood 
-0.09(1.0) 0.05(1.1) 0.24(0.8)* -0.07(1.0) 0.04(1.0) 0.24(0.8) -0.04(1.0) 0.005(1.0) 0.12(0.9)* -0.06(1.0) 0.05(1.0) 0.40(0.9) 
SBP at 5 years of age/mmHg 110(12.0) 103.7(8.1) 130.9(10.4)*** 100.6(9.1) 113.6(10.9) 113.1(13.7)*** -   -   
DBP at 5 years of age/mmHg -   -   61.4(7.8) 64.9(8.1) 76.7(9.8)*** 60.4(7.0) 67.0(8.6) 69.6(8.2)*** 
Parity :   ≤2 162(36.8) 262(35.1) 17(28.3) 206(47.8) 265(31.8) 19(32.8)*** 305(34.2) 130(38.8) 6(28.6) 207(43.1) 278(33.7) 5(29.4)** 
>2 278(63.2) 484(64.9) 43(71.7) 225(52.2) 568(68.2) 39(67.2) 585(65.7) 205(61.2) 15(71.4) 273(56.9) 547(66.3) 12(70.6) 
SES in infancy 3(2) 3(2) 3(2) 3(2) 3(2) 3(2) 3(2) 3(2) 3(1) 3(2) 3(2) 3(1)* 
*Model showing the summary statistics of factors associated with the BP trajectories   with level of significance: ***p<0.001, **p<0.01, *p<0.05 
†Analysis of variance for continuous exposures (gestational age, birth weight, weight and linear growth between 0-2yrs, 2-5yrs, BP at 5yrs and asset-based SES score) and chi square test for categorical variable, parity, associated with the BP trajectories 
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Table 3 Association of birth weight relative weight gain and linear growth in infancy and mid-childhood, and   SBP trajectory groups between 5 and 18 years (OR, 
95%CI, p value) 
A. BOYS 
Middle vs Lower trajectory group 
Model 1 Model 2 Model 3 Model 4 
OR 95%CI P value OR 95%CI P value OR 95%CI P value OR 95%CI P value 
Birth weight(z score) 1.02 0.76-1.38 0.8736 0.99 0.73-1.35 0.9738 0.77 0.6-0.98 0.0307 0.75 0.58-0.96 0.0223 
Relative weight gain in infancy 1.54 1.14-2.09 0.0050 1.65 1.2-2.26 0.0021 1.21 0.95-1.55 0.1237 1.23 0.96-1.59 0.1046 
Relative weight gain in mid-childhood 1.20 0.94-1.54 0.1522 1.28 0.96-1.7 0.0918 1.25 0.99-1.57 0.0653 1.26 0.98-1.62 0.0712 
Relative linear growth in infancy 1.76 1.28-2.43 0.0005 1.72 1.26-2.35 0.0007 0.84 0.64-1.11 0.2157 0.84 0.64-1.11 0.2299 
Relative linear growth in mid-childhood 1.65 1.24-2.18 0.0005 1.58 1.19-2.11 0.0018 0.85 0.67-1.09 0.2021 0.89 0.7-1.15 0.3774 
Upper vs Lower trajectory group          
Birth weight(z score) 1.03 0.7-1.51 0.8705 1.02 0.66-1.56 0.9453 0.69 0.31-1.55 0.3652 0.67 0.28-1.61 0.3685 
Relative weight gain in infancy 1.58 1.08-2.33 0.0190 1.67 1.09-2.56 0.0196 3.74 1.43-9.83 0.0074 4.11 1.25-13.51 0.0202 
Relative weight gain in mid-childhood 1.34 0.95-1.89 0.0950 1.36 0.92-2.02 0.1221 1.21 0.59-2.48 0.6088 1.20 0.54-2.65 0.6604 
Relative linear growth in infancy 2.15 1.41-3.28 0.0004 2.18 1.39-3.43 0.0007 1.62 0.67-3.93 0.2847 1.98 0.71-5.48 0.1912 
Relative linear growth in mid-childhood 1.44 1-2.09 0.0513 1.53 1.02-2.3 0.0400 1.02 0.44-2.34 0.9645 1.12 0.39-3.2 0.8392 
B.GIRLS            
122 
 
 
 
*The multinomial logistic regression showing odds ratios, 95% confidence intervals and the p values from GBTM showing: 
†Model 1: Multinomial logistic regression of growth variables and SBP trajectory classes adjusted for gestational age (time-invariant covariate-a proxy for intrauterine environment). 
Model 2: Multinomial logistic regression of growth variables and SBP trajectory classes adjusted for gestational age, parity, SES in infancy, maternal age (time-invariant covariates-intrauterine environment and maternal factors). 
Model 3: Multinomial logistic regression of growth variables and SBP trajectory classes with height as time-varying covariate (a marker of childhood environment) and gestational age as a time-invariant covariate. 
Model 4: Multinomial logistic regression of growth variables and SBP trajectory classes with height as time varying covariate and gestational age, parity, SES in infancy, and maternal age as a time-invariant covariates. 
 
Middle vs Lower trajectory group             
Birth weight(z score) 1.23 0.93-1.63 0.1490 1.12 0.85-1.48 0.4309 1.09 0.84-1.42 0.5190 0.97 0.73-1.28 0.8223 
Relative weight gain in infancy 1.39 1.04-1.86 0.0276 1.37 1.02-1.85 0.0350 1.33 1.02-1.75 0.0378 1.33 1-1.76 0.0492 
Relative weight gain in mid-childhood 1.00 0.75-1.32 0.9802 1.09 0.81-1.46 0.5669 1.11 0.85-1.44 0.4507 1.22 0.93-1.59 0.1546 
Relative linear growth in infancy 2.11 1.51-2.94 0.0000 2.07 1.48-2.91 0.0000 1.60 1.15-2.21 0.0053 1.58 1.15-2.17 0.0046 
Relative linear growth in mid-childhood 1.14 0.87-1.49 0.3394 1.12 0.85-1.48 0.4209 1.03 0.79-1.36 0.8098 1.01 0.75-1.35 0.9578 
Upper vs Lower trajectory group          
Birth weight(z score) 1.34 0.93-1.94 0.1123 1.31 0.89-1.92 0.1682 1.35 0.94-1.94 0.1043 1.27 0.86-1.88 0.2246 
Relative weight gain in infancy 1.67 1.14-2.44 0.0085 1.59 1.06-2.37 0.0236 1.69 1.14-2.5 0.0084 1.63 1.08-2.46 0.0211 
Relative weight gain in mid-childhood 1.65 1.18-2.31 0.0038 1.76 1.22-2.55 0.0026 1.69 1.2-2.38 0.0026 1.77 1.22-2.56 0.0025 
Relative linear growth in infancy 2.35 1.59-3.48 0.0000 2.23 1.48-3.35 0.0001 1.98 1.33-2.96 0.0008 1.90 1.27-2.86 0.0019 
Relative linear growth in mid-childhood 1.95 1.37-2.78 0.0002 1.99 1.36-2.91 0.0004 2.03 1.38-2.99 0.0003 2.12 1.39-3.23 0.0005 
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Table 4 Association of birth weight relative weight gain and linear growth in infancy and mid-childhood, and   DBP trajectory groups between 5 and 18 years (OR, 
95%CI, p value)* 
A. BOYS Model 1 Model 2 Model 3 Model 4 
Middle vs Lower trajectory group OR 95%CI P value OR 95%CI P value OR 95%CI P value OR 95%CI P value 
Birth weight(z score) 0.97 0.72-1.33 0.8688 0.99 0.71-1.38 0.9371 0.82 0.64-1.06 0.1359 0.83 0.63-1.10 0.2019 
Relative weight gain in infancy 1.73 1.23-2.42 0.0015 1.76 1.22-2.56 0.0028 1.37 1.04-1.8 0.0251 1.43 1.06-1.95 0.0214 
Relative weight gain in mid-childhood 1.37 1.01-1.85 0.0447 1.44 1.03-2.01 0.0351 1.22 0.96-1.56 0.1029 1.26 0.96-1.64 0.0926 
Relative linear growth in infancy 1.02 0.71-1.46 0.9100 1.13 0.76-1.67 0.5598 0.72 0.55-0.94 0.0171 0.78 0.58-1.05 0.1001 
Relative linear growth in mid-childhood 1.51 1.06-2.15 0.0228 1.68 1.19-2.38 0.0034 0.97 0.75-1.24 0.8032 1.14 0.86-1.52 0.3633 
Upper vs Lower trajectory group          
Birth weight(z score) 0.93 0.65-1.34 0.7133 0.93 0.63-1.36 0.7017 0.81 0.46-1.42 0.4609 0.68 0.45-1.03 0.0658 
Relative weight gain in infancy 1.57 0.98-2.52 0.0614 1.77 1.16-2.72 0.0087 1.03 0.55-1.90 0.9359 1.38 0.89-2.15 0.1519 
Relative weight gain in mid-childhood 1.12 0.72-1.72 0.6190 1.40 0.94-2.08 0.0976 0.93 0.56-1.54 0.7739 1.37 0.88-2.13 0.1627 
Relative linear growth in infancy 1.21 0.81-1.81 0.3535 1.17 0.76-1.78 0.4787 0.75 0.36-1.56 0.4392 0.47 0.29-0.76 0.0021 
Relative linear growth in mid-childhood 1.75 1.20-2.54 0.0036 1.83 1.23-2.71 0.0028 1.05 0.63-1.76 0.8473 0.80 0.53-1.21 0.2848 
B.GIRLS             
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Middle vs Lower trajectory group             
Birth weight(z score) 1.07 0.86-1.35 0.5310 1.02 0.80-1.30 0.8553 1.03 0.82-1.30 0.7790 0.99 0.78-1.26 0.9339 
Relative weight gain in infancy 1.36 1.07-1.73 0.0108 1.27 0.99-1.63 0.0611 1.31 1.03-1.67 0.0265 1.27 0.98-1.63 0.0677 
Relative weight gain in mid-childhood 1.23 1.00-1.51 0.0511 1.30 1.04-1.63 0.0234 1.20 0.97-1.47 0.0956 1.28 1.02-1.61 0.0317 
Relative linear growth in infancy 1.27 1.01-1.59 0.0392 1.24 0.97-1.58 0.0809 1.15 0.89-1.47 0.2858 1.08 0.83-1.42 0.5544 
Relative linear growth in mid-childhood 1.28 1.03-1.58 0.0234 1.27 1.00-1.60 0.0460 1.18 0.94-1.48 0.1502 1.17 0.91-1.49 0.2205 
Upper vs Lower trajectory group          
Birth weight(z score) 1.16 0.44-3.06 0.7615 1.47 0.73-2.97 0.2830 1.46 0.72-2.95 0.2944 1.44 0.68-3.03 0.3379 
Relative weight gain in infancy 4.25 1.51-11.94 0.0061 2.90 1.36-6.18 0.0057 2.65 1.25-5.58 0.0106 2.53 1.14-5.57 0.0219 
Relative weight gain in mid-childhood 1.08 0.47-2.48 0.8640 1.58 0.81-3.10 0.1835 1.47 0.77-2.82 0.2468 1.52 0.80-2.90 0.2047 
Relative linear growth in infancy 0.88 0.37-2.14 0.7856 1.07 0.55-2.10 0.8396 0.88 0.44-1.74 0.7039 1.00 0.49-2.02 0.9942 
Relative linear growth in mid-childhood 2.20 0.90-5.36 0.0840 1.56 0.80-3.04 0.1950 1.52 0.80-2.90 0.1996 1.48 0.74-2.96 0.2715 
*Multinomial logistic regression models showing the odds ratios, 95%  confidence intervals and p values of the association between growth and BP trajectories: 
†Model 1: Multinomial logistic regression of growth variables and DBP trajectory classes adjusted for gestational age (time-invariant covariate). 
Model 2: Multinomial logistic regression of growth variables and DBP trajectory classes adjusted for gestational age, parity, SES in infancy, maternal age (time-invariant covariates). 
Model 3: Multinomial logistic regression of growth variables and DBP trajectory classes with height as time-varying covariate and gestational age as a time-invariant covariate. 
Model 4: Multinomial logistic regression of growth variables and DBP trajectory classes with height as time varying covariate and gestational age, parity, SES in infancy and maternal age as a time-invariant covariates.
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PART 3: GENERAL DISCUSSION 
 
 
 
 
“It is easier to build strong children than repair broken men…” 
Frederick Douglass (1818-1895) 
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6 CHAPTER 6: GENERAL DISCUSSION  
This chapter is the synthesis of consolidated findings with regards to key objectives of this thesis. 
It also comprises of reflections on the emerging themes, conceptual and contextual relevance, the 
strengths and limitations, future research and the conclusion.  
 
6.1 Summary of study findings  
The overarching objective of this study was to describe the BP profiles in BT20 between ages 5 
and 18 years and to examine the impact of early growth on the longitudinal BP trajectories.  The 
consolidated findings in line with the objectives of the study are outlined in table 6-1 
 
Table 6-1 Consolidated study findings 
 
Chapter  Objective Key findings 
3  Assess the prevalence 
of elevated BP 
High prevalence of hypertension at as early as age 5 
years (22.4%). 
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 between 5 to 18 years 
3  Examine BP tracking 
between ages 5 and 18 
years  
Low to moderate tracking of BP between 5 and 18 years 
of age and 36.1% of children above the 90
th
 percentile 
for age, sex and height at 5 years of age maintained the 
elevated BP status at mean age 18 years. The relative risk 
of remaining in the elevated BP status compared to 
remaining in the normative range between 5 and 18 years 
of age was 60%: (OR1.60: 95%CI:1.29-2.00). 
4  Examine the 
association between 
SES change in 
childhood, and BP at 
18 years of age 
Upward social mobility compared to a persistent low 
SES between infancy and adolescence was significantly 
associated with a 5mmHg lower SBP (β= -4.85 : 95% 
CI:-8.22 to -1.48, p<0.01) 
5  Identify distinct BP 
trajectories 
Three distinct sex-specific trajectory group memberships 
for BP were identified using group based trajectory 
modeling: “lower”, “middle” and “upper.” 
Height between ages 5 and 18 years and cubic age terms 
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were positively associated with BP trajectories except for 
girls upper SBP and DBP. 
5  Assess the association 
of early-life growth 
and  BP trajectories 
between ages 5 and 18 
years,  
Accelerated weight accrual and linear growth were 
associated with the upper compared to the lower SBP 
trajectory in girls 
In boys, increased birth weight and faster relative weight 
gain in infancy were major predictors of the middle and 
the upper trajectories compared to the lower one.  
The associations between early growth and DBP 
trajectory group membership were inconsistent. 
 
6.1.1 Hypotheses re-visited 
In the context of the consolidated findings, I revisited the hypotheses for this thesis.   
 
Hypothesis 1:   Elevated BP does not track from childhood to adulthood 
We reject the hypothesis that stated that BP does not track from childhood to adulthood in this 
theses and suggest that there is a low-to-moderate degree of tracking with regards to tracking 
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coefficients and almost one in three children  maintain an elevated BP status between 5 and 18 
years of age.   
 
Hypothesis 2: There is no relationship between SES change and later BP 
There is an association between an upward SES change between infancy and adolescence and 
SBP hence we reject the hypothesis that a change in SES does not predict BP.  However, this 
hypothesis held for DBP, MAP and hypertension status. 
 
Hypothesis 3: There are no distinct BP trajectories between 5 and 18 years of age 
We have also rejected the assumption of homogeneity in longitudinal BP throughout childhood 
and concluded that there are distinct patterns of BP change over time.  
 
Hypothesis 4: Early growth in infancy and mid-childhood is not related to BP trajectories 
independent of height 
Trajectories of BP change over time are associated with some patterns of early life growth hence 
the assumption that early growth is not associated with BP between childhood and adulthood 
fails to hold in this present study. 
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6.2 Emerging research themes from the findings 
Based on the consolidated findings of this thesis and the relevant literature, the emerging themes 
are: (1) early emergence of high BP which is sustained to early adulthood; (2) Sub-groups of 
individuals can be identified as having  distinct patterns of BP over time, and (3) early growth 
and increases in stature predict  age-related BP changes over time. 
 
6.2.1 Early establishment and persistence of elevated BP  
 This thesis has helped me reflect back to my cardiovascular physiology classes as an 
undergraduate student.  We were taught that BP increases with age along with height and weight 
in a growing child.  However, strikingly new perspectives to high BP in this study are the early 
onset in children as long as 5 years of age and the persistence of elevated BP into early adulthood 
in one in three children.  Though this was based on BP readings on one occasion,  the current 
paediatric high BP estimates tend to reflect the current state of adult hypertension in South 
Africa which is home to the most hypertensive population  worldwide, with  prevalence of 30 to 
40 % over the recent years,  and in a younger individuals compared to  other regions of the world 
(250).  
 
Childhood hypertension often goes unnoticed with its subtle ripple effects often manifesting only 
in adulthood with complications may not be reversed.  This implies that by the time hypertension 
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is detected in adulthood, considerable damage may have occurred to the arterial system, heart, 
and other organs related to BP control. These physiological and metabolic markers may be 
detected in children using non-invasive to assess the extent of vascular injury or end organ 
damage in childhood (20, 251).  
 
6.2.2 The dynamics of SES and SBP 
Children are born into socially and economically diverse environments which may set in motion 
a cascade of delicate biological and metabolic responses upon which trajectories of BP are set for 
life. Socioeconomic disparities in South Africa are an intense aftermath of the apartheid regime 
which left black South Africans in poor housing conditions, low income and education levels 
compared to their white counterparts. At the dawn of the post -apartheid era, still inequalities 
among black people exists with the majority still falling short of key socioeconomic indicators 
like employment and education (252).  
 
This study provided a new dimension in social epidemiology in the South African context  by 
highlighting that BP was lower among black children whose SES improved between infancy and 
compared to those who had persistent low SES. It is not clear whether these findings will hold as 
the wave of transition continues to sweep across this South African black population.  There is 
strong evidence to confirm social patterning of BP in both HICs and LMICs, though the 
132 
 
 
gradients differ from setting to setting.  HTN is more prevalent in urban versus rural areas due to 
the nutrition transition (253), and in urban areas  high BP disproportionately affect the poor 
compared to the rich (254).  
 
6.2.3 Stature and childhood BP trajectories 
Many key organs responsible for BP control are developed and set by birth for example the 
number of nephrons are set at birth. This implies that environment prior and during gestation 
may set a child in a particular course of BP development over time.  In response to growth and 
development of a child, variations in BP could be identified in this study as early as at 5 years of 
age.  We found out that early rapid growth along with stature were significant drivers of the BP 
trajectories, especially in the upper trajectories of SBP.  These findings confirm the importance 
of height in paediatric BP.   
 
The role of height in BP in children and adolescents has been reported elsewhere , with a unit 
increase in height significantly predicted almost a 2mmHg increase in SBP and a 1mmHg in 
DBP in Indian (199) and American children (255). However, most studies modelling 
longitudinal blood pressure in children and teenagers often overlook the influence of height on 
BP of a growing child mainly because of the complexities related to its inclusion in the models. 
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The challenge with modeling height as a time varying covariate in Mplus was convergence 
issues leading to the use of  GBTM in a STATA plug in program developed by Jones and Nagin 
(243, 256).  Both GMM and GBTM are useful in establishing distinct patterns of BP change over 
time which might be of conceptual and empirical relevance for policy and clinical practice as 
they provide a non-parametric presentation of a continuous variable like BP. These trajectory 
groups may be useful in identifying children with anomalous BP patterns and their key 
characteristics and possible underlying biological mechanisms.   
 
The advantage of GBTM over GMM in MPlus is that GBTM does not assume a normal 
distribution of the variable in a population, but uses statistical algorithms to estimate the 
unknown distribution of the trajectories across a given population.  On the other hand, GMM 
works on assumption that the population comprises at least two subgroups, each of which 
follows a growth curve model with random effects. GBTM produces a visual summary of the 
trajectory groups with confidence intervals depicting the level and change of the trajectory 
group. However, there is an assumption of no individual variation around the mean group 
trajectory since it is constrained to zero hence there is no detail on variation within trajectory 
group with regards to level and rate of change (257).   
 
My recommendation is that choice of use of either GMM or GBTM should be based on the 
research question, conceptual framework and the intended use of information on BP trajectories. 
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For instance if the research question focusses on understanding individual variation in a 
particular trajectory group, then GMM should be a preferred option but if there objective is to 
assess factors associated with group membership, then the need for individual variation within a 
group may be relaxed.   
 
6.3 Conceptual relevance 
The conceptual framework for this thesis was selected based on its life course approach to 
chronic diseases and how growth and societal factors across the life span influences hypertension 
risk.  Based on the relevant literature, overall research objective, key findings and emerging 
themes of this thesis, major modification to the conceptual framework are: (1) persistence of BP 
status along with increasing stature and early establishment of sub-groups of individuals with 
distinct patterns of BP over time, (2) improving socioeconomic status between childhood and 
adolescence reduces SBP and (3) use of conditional relative weight and height gain as proxies 
for rapid growth may be useful in dealing with multicolinearity in life course models.  These 
major modifications are highlighted in red in Figure 6-2  
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Figure 6-2 A modified conceptual framework on life course approach to chronic diseases prevention 
Relative weight gain 
Relative linear growth 
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6.4 Study relevance-locally and internationally 
Early establishment of elevated BP is relevant for policy, practice and research for several 
reasons.  Firstly, detection and prevention of elevated BP should start earlier in life before 
emergence of complications related to high BP which could be more costly to eradicate or 
manage.  Secondly, interventions should target optimal growth in early life though maternal 
nutrition before or during pregnancy, promotion of exclusive breastfeeding, appropriate weaning 
practices and low-calorie in childhood. This body of work has highlighted that elevated BP may 
be established earlier in life.  Thirdly, since poor household condition in early life is a critical 
puzzle in BP etiology, there is need to address social disparities to improve child health by 
addressing household needs, health services and improving maternal education and 
empowerment and ownership.  
 
These findings have theoretical relevance for policy, practice and research and call for a multi-
stakeholder approach to early detection, public health awareness, prevention and control of high 
blood pressure in children and adolescents by global health bodies, civil society groups, health 
practitioners, researchers, community and parents or caregivers.  There is need for policy 
formulation and action around reducing the burden attributable to hypertension beginning in 
early life.  Against increasing evidence to suggest that hypertension is established in early life, 
there is need to raise public awareness and engagement on paediatric HTN, its risk factors, 
complications and prevention strategies.   
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Early detection may pose long term benefits hence there is need to advocate for inclusion of 
routine BP checks along with growth monitoring in children.  Currently, there is no consensus on 
BP classification criteria hence researchers and paediatric practice need to develop valid, reliable 
and universally easy-to use BP normative charts to make detection of hypertension in children 
and adolescents as easy as in adults.  Emulating the Chinese BP reference charts, South Africa 
should establish national BP normative charts to which are representative of the local population.  
 
There is need for policies that safeguard paediatric population against risk factors for elevated 
BP in childhood, for example, marketing of high salt, empty calorie foods to children and 
controlled food vending around schools, sedentary lifestyles by engaging parents, schools and 
government to promote healthy lifestyles and physical education.  In South Africa, there is need 
for the Ministries of Education, Social development and Health to reinforce policies which 
promote healthy lifestyles from as early as preschool like compulsory physical education in 
schools and curriculum on healthy lifestyles. 
 
6.5 Strengths and limitations 
This study has potential to infer causality by virtue of its prospective cohort design with long 
term follow up from birth to 18 years. The study sample was large, increasing external validity. 
The excluded sample was also comparable to the analytical sample.  Data for this study were 
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collected prospectively and the validated questionnaires for SES and anthropometry were 
consistent over time minimizing information bias.  
 
The cohort had repeated measures of BP over seven occasions, measured by trained research 
assistants. The use of automated BP machines minimized observer bias compared to the 
sphygmomanometer where the observer’s ability to detect the Korotkoff sound for DBP 
measurement is highly subjective. Furthermore three measurements of BP were obtained at each 
occasion and the second and third measurements were averaged to represent the BP at a given 
time point thereby minimizing white coat effect.  Potential confounders were measured during 
data collection and adjusted accordingly in all the multivariate analyses increasing the potential 
of this study to establish causality.  
 
Despite a number of the strengths, some issues have to be acknowledged as potential 
shortcomings. Firstly, loss due to follow up in this cohort study (less than 25% overall) was 
inevitable due to deaths and migrations and other reasons. Comparisons on key variables for 
those who were retained in the analyses and those who were excluded for each research objective 
enhanced external validity.  For longitudinal analyses, after exploratory analyses, we made an 
assumption that BP data were missing at random (MAR). The GBTM technique employed 
maximum likelihood estimation to deal with potential bias related to missing data.  
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Measurement of BP using two different automated machines (the Dinamap at age 5, and Omron 
from 8 years onwards) may have introduced differential misclassification in BP in childhood 
time points. However, there is evidence to suggest that there are no major differences with 
regards to BP measurements in pediatrics using the two automated machines (258).  
 
We also noted that the proportions of individuals in the downward mobility group were very 
small hence this might have affected statistical power in the multivariate analyses.  The problem 
of repeated measures of early life growth is that they were strongly correlated. To account for 
this we computed conditional variables to reduce multi-collinearity.  The associations between 
early growth and the upper DBP trajectory membership were inconsistent, probably because of 
low statistical power due to low proportions in those groups. 
 
6.6 Future research 
Based on the findings from this thesis, we postulate that it is possible to identify children with 
persistent elevated BP in childhood and that there could be underlying bio-physiological 
mechanisms driving BP in children. Future research has to: 
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1. Confirm the estimates of elevated BP in children starting from age 5 years in the Soweto, 
Johannesburg to reinforce the rationale to prioritise hypertension screening in children. 
 
2. Evaluate the feasibility of screening children for primary hypertension by assessing 
absolute risk and intention to treat.  
 
3. Establish the clinical hypertension status in this cohort study and to assess the 
biochemistry, cardiovascular physiology (arterial stiffness, early cardiovascular aging) 
and kidney function to understand the underlying mechanisms in relation to the BP 
trajectories identified in this current thesis. 
 
4. Prioritise development of valid, easy to implement and simplified paediatric BP 
measurement protocols and normative definitions that can be used in diverse settings to 
establish global and regional trends in paediatric hypertension 
 
6.7 Conclusions 
In conclusion, this thesis demonstrated the importance of examining childhood BP because 
elevated BP tracks into adulthood independent of the biological effect of height. It also 
highlighted the importance of optimizing growth and socioeconomic environment in the early 
life period upon which key foundations for BP variations are created. This can be achieved 
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through promoting breastfeeding in infancy and appropriate weaning diet, physical activity in 
childhood and reducing the social inequality inherited from the apartheid era
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   Birth to Twenty Questionnaire Anthropometry and SES sections Appendix 1
 
 
  
  
 
Consent Table (Initial the appropriate column) 
 
 
 
 
 
 
PARTICIPATION IN BIRTH TO TWENTY CONSENT 
Components Yes No 
Core Questionnaire     
Anthropometric Measurements   
Contact details of a relative or a friend who will always know where you live (different to information 
on contact sheet): 
Name:  ___________________  Relationship: _______________________ 
Landline number: ___________________  Cell number: _______________________ 
Work number: ___________________  Other:  _______________________ 
Address: _____________________________________________________________________ 
  
175 
 
I agree to myself being a participant in Birth to Twenty study 
The goals and methods of the study are clear to me. 
I understand that the study will involve interviews. All the details and purposes of this 
study have been explained to me. I understand that I have the right to refuse to 
participate in the study. 
 
I agree to participation in Birth to Twenty study on condition that: 
 
1. I can withdraw from the study at any time voluntarily and that no adverse 
consequences will follow on withdrawal from the study. 
 
2. I have the right not to answer any or all questions posed in the interviews and not 
to participate in any or all of the procedures / assessments. 
 
3. The University of the Witwatersrand Human Ethics committee has approved the 
study protocol and procedures. 
 
4. All results will be treated with the strictest confidentiality. 
 
5. Only group results, and not my individual results, will be published in scientific 
journals and in the media. 
 
6. The study scientific team are committed to treating participants with respect and 
privacy through interviews conducted in private and follow-up counselling available 
on request.   
 
  
176 
7. I will receive a referral note to a health service if any result is out of the normal 
range or a problem is detected in the course of the study. 
 
 
PARTICIPANT: 
 
 
 
 
Printed Name   Signature / Mark or Thumbprint  Date and 
Time 
 
 
 
 
 
RESEARCH ASSISTANT: 
 
 
 
 
Printed Name    Signature    Date and 
Time 
SURVEY CONSENT 
 
I agree to myself being a participant in the study 
  
177 
The goals and methods of the study are clear to me. 
I understand that the study will involve interviews. All the details and purposes of this 
study have been explained to me. I understand that I have the right to refuse to 
participate in the study. 
 
I agree to participation in the study on the condition that: 
 
1. I can withdraw from the study at any time voluntarily and that no adverse 
consequences will follow on withdrawal from the study. 
 
2. I have the right not to answer any or all questions posed in the interviews and not 
to participate in any or all of the procedures / assessments. 
 
3. The University of the Witwatersrand Human Ethics committee has approved the 
study protocol and procedures. 
 
4. All results will be treated with the strictest confidentiality. 
 
5. Only group results, and not my individual results, will be published in scientific 
journals and in the media. 
 
6. The study scientific team are committed to treating participants with respect and 
privacy through interviews conducted in private and follow-up counselling available 
on request.   
 
7. I will receive a referral note to a health service if any result is out of the normal 
range or a problem is detected in the course of the study. 
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PARTICIPANT 
 
Printed Name           Signature / Mark or Thumbprint  Date and  
Time 
 
RESEARCH ASSISTANT: 
 
Printed Name   Signature    Date and 
Time 
Research Assistant:         Date: 
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SECTION 3 HOUSEHOLD SES 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
180 
SECTION 7: MEASUREMENTS  
ANTHROPOMETRY 
 STANDING HEIGHT: (mm) 
 SITTING HEIGHT: (mm) 
 WEIGHT: (kg) 
 WAIST CIRCUMFERENCE: (mm) 
 HIP CIRCUMFERENCE: (mm) 
 
 
BLOOD PRESSURE 
 SYSTOLIC BP 
 DIASTOLIC BP 
 PULSE 
 TIME OF BP 
 
 
 
 
Research Assistant:             Date: 
 
 
 
SELF COMPLETE Q: RA:             Date: 
 
Y  N 
 
  
 
  
   
h 
 
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QUALITY CHECKED BY:                DATE:  
 
 
 
 
 
 
 
Notes: 
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  The ethics clearance certificate  Appendix 2
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  Comparison of the Study Sample that had BP status measured at ages 5 and 18 years and those who did not. Appendix 3
Baseline variables 
(5years) 
N BP status at both 
ages 5 and 18 
years 
N No BP status at 
both ages 5 and 18 
years 
P value 
SBP(mmHg) 895  108±13 7  109±15  0.8524 
DBP(mmHg) 859 63±8 7  (64±8) 0.6664 
Height(cm) 859 107.8±4.5 80 (106.9±3.2) 0.0722 
Weight(kg) 859 18.3±2.3 210 (18.2±2.0) 0.6855 
BMI 859 15.6±1.3 80 (16.1±1.6) 0.0012 
Sex: Males (%) 429 50.0 406 50.0 0.981 
        Females (%) 430 50.1 406 50.0 
t-test and chi square test conducted for continuous variables and categorical variable, respectively. 
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  Bivariate analysis of factors associated with blood pressure and hypertension risk in urban South African black Appendix 4
participants aged 18 years (n=838) 
  SBP DBP MAP Hypertension risk 
Exposure variables β 95% CI p value β 95% CI p value β 95% CI p value OR 95% CI 
p 
value 
SES change                         
Low-low (ref) 
 
    
 
    
 
    1     
Low-medium -0.89 -3.34-to 1.56 0.474 -0.39 -2.38 to 1.60 0.702 -0.54 -2.47 to 1.40 0.586 0.95 0.51 to 1.77 0.865 
Low-high -4.94 -8.64-to  -1.23 <0.01 -2.24 -5.26 to 0.77 0.144 -2.78 -5.71 to 0.14 0.062 0.14 0.02 to 1.06 0.057 
Medium-low -0.13 -2.56 to 2.30 0.916 1.12 -0.86 to 3.10 0.266 0.61 -1.31 to 2.53 0.534 0.79 0.41 to 1.52 0.478 
Medium-Medium -1.39 -4.15 to 1.36 0.321 -0.34 -2.58 to 1.90 0.765 -1.15 -3.33 to 1.03 0.301 0.79 0.37 to 1.65 0.526 
Medium-high 0.50 -2.88 to 3.89 0.771 -0.23 -2.99 to 2.52 0.869 -1.16 -2.83 to 2.52 0.909 0.63 0.24 to 1.69 0.361 
High-low -2.29 -4.95 to 0.36 0.091 -1.69 -3.85 to 0.47 0.125 -1.63 -3.73 to 0.47 0.128 0.79 0.38 to 1.61 0.512 
High-Medium -0.23 -2.85 to 2.39 0.865 1.02 -1.11 to 3.15 0.348 0.63 -1.44 to 2.70 0.548 1.00 0.52 to 1.94 0.995 
High-high -2.31 -4.95 to 0.34 0.087 -0.41 -2.56 to 1.74 0.711 -1.21 -3.30 to 0.88 0.256 0.62 0.29t o 1.33 0.216 
Participant characteristics                         
Childhood                          
Gestational age, weeks 0.01 -0.37 to 0.41 0.943 0.03 -0.28 to 0.35 0.836 0.03 -0.27 to 0.34 0.826 0.97 0.88 to 1.07 0.559 
Birth weight, kg 0.40 -0.98 to 1.78 0.568 -0.12 -1.24 to 1.01 0.836 0.00 -1.09 to 1.09 0.999 0.96 0.67 to 1.40 0.861 
Small-for-Gestational age(SGA),%                         
No(ref) 
 
    
 
    
 
    1     
Yes 2.02 -0.16 to 4.19 0.069 -0.05 -1.83 to 1.74 0.96 0.76 -0.95 to 2.48 0.383 1.56 0.92  to 2.66 0.099 
Adolescence                          
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Age, years 2.81 0.98 to 4.65 <0.001 -1.1 -2.61 to 0.40 0.15 0.11 -1.35 to 1.56 0.887 1.41 0.86 to 2.30 0.172 
Sex                         
Boys(ref) 
 
    
 
    
 
    1     
Girls -6.10 -7.41 to -4.77 <0.001 1.19 0.07 to 2.31 0.04 -0.81 -1.90 to 0.27 0.142 1.00 0.69 to 1.45 0.99 
Alcohol intake              
No          1   
Yes -1.05 -2.40 to 0.31 0.131 -0.23 -1.38 to 0.93 0.701 -0.50 -1.61 to 0.61 0.378 0.81 0.57 to 1.16 0.259 
Smoking              
No          1   
Yes -1.29 -2.69 to 0.11 0.071 0.93 2.41 to 0.55 0.217 -1.06 -2.69 to 0.57 0.201 0.72 0.44 to 1.19 0.203 
             
Weight at age 18yrs, kg 0.25 0.19 to 0.30 <0.001 0.12 0.07 to 0.17 <0.001 0.17 0.13 to 0.22 <0.001 1.04 1.02 to 1.063 <0.001 
Height at age 18yrs,cm 0.35 0.27 to 0.42 <0.001 0.00 -0.07 to 0.06 0.888 0.10 0.04 to 0.17 <0.01 0.99 0.97 to 1.01 0.236 
Relative weight gain (0-2years) 0.87 0.15 to 1.59 0.02 0.45 -0.14 to 1.04 0.135 0.56 0.00 to 1.13 0.051 1.13 0.94 to 1.38 0.194 
Relative weight gain (2-4years) 0.64 -0.02 to 1.30 0.058 0.12 -0.42  to 0.66 0.652 0.48 -0.04 to 1.00 0.068 1.28 1.07 to 1.55 <0.01 
Relative weight gain (4-18years) 2.56 1.86 to 3.26 <0.001 1.29 0.71 to 1.87 <0.001 1.77 1.22 to 2.32 <0.001 1.59 1.30 to 1.93 <0.001 
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 Additional multivariate analyses of factors associated with blood pressure and hypertension risk in urban South Appendix 5
African black participants aged 18 years. 
  SBP¹(n=655) DBP¹(n=655) MAP¹(n=655) Hypertension  risk²(n=653) 
  β 95% (CI) p value β 95% (CI) 
p 
value β 95% (CI) 
p 
value 
Odds 
Ratio 95% (CI) 
P 
value 
SES change                                 
Low-low(ref)                                 
Low-medium -1.35 -4.19 1.49 0.350 -0.60 -3.12 1.92 0.639 -0.86 -3.27 1.55 0.482 0.61 0.28 1.34 0.215 
Low-high -4.78 -8.92 -0.65 0.024 -0.34 -4.02 3.33 0.855 -1.77 -5.28 1.73 0.321 0.27 0.06 1.23 0.091 
Medium-low -0.85 -4.38 2.67 0.634 0.98 -2.16 4.11 0.540 0.35 -2.64 3.34 0.820 0.56 0.22 1.45 0.232 
Medium-Medium -3.64 -7.59 0.32 0.071 -1.69 -5.21 1.82 0.344 -2.37 -5.72 0.99 0.166 0.45 0.15 1.35 0.153 
Medium-high 1.07 -3.14 5.28 0.619 1.19 -2.56 4.93 0.533 1.15 -2.43 4.72 0.528 0.64 0.20 2.05 0.458 
High-low -4.28 -9.26 0.71 0.093 -1.06 -5.49 3.38 0.640 -2.15 -6.38 2.08 0.319 0.43 0.10 1.77 0.243 
High-Medium -0.99 -5.89 3.90 0.691 2.81 -1.54 7.16 0.204 1.53 -2.62 5.69 0.469 0.46 0.12 1.75 0.254 
High-high -3.54 -8.76 1.68 0.184 0.99 -3.66 5.63 0.676 -0.52 -4.95 3.91 0.818 0.50 0.12 2.13 0.351 
Current participant age, yrs 2.45 0.26 4.64 0.028 -1.03 -2.98 0.91 0.298 0.14 -1.71 2.00 0.879 
    Current participant height, cm 0.08 -0.05 0.21 0.227 -0.02 -0.13 0.10 0.761 0.01 -0.09 0.12 0.808 
    Baseline BP  at 5 yrs 0.13 0.07 0.19 0.000 0.18 0.09 0.27 0.000 0.16 0.08 0.24 0.000 1.38 0.84 2.29 0.204 
Household SES in infancy   0.29 -0.95 1.53 0.650 -0.39 -1.49 0.71 0.489 -0.16 -1.21 0.89 0.770 1.05 0.74 1.48 0.782 
Current alcohol intake  -0.71 -2.31 0.90 0.386 0.13 -1.29 1.56 0.854 -0.16 -1.52 1.20 0.822 0.84 0.54 1.32 0.454 
Sex -4.98 -7.17 -2.78 0.000 1.26 -0.71 3.22 0.210 -0.82 -2.69 1.05 0.390 
    small for gestational age(SGA) 2.00 -0.45 4.45 0.109 0.45 -1.73 2.63 0.687 0.93 -1.15 3.01 0.379 1.87 1.05 3.32 0.033 
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Relative weight gain (0-2years) 1.19 0.35 2.03 0.005 0.53 -0.22 1.27 0.166 0.75 0.04 1.46 0.039 1.13 0.90 1.43 0.301 
Relative weight gain (2-4years) 0.35 -0.38 1.09 0.348 0.32 -0.33 0.97 0.340 0.32 -0.31 0.94 0.319 1.21 0.98 1.48 0.072 
Relative weight gain (4-18years) 3.43 2.62 4.24 0.000 1.38 0.65 2.10 0.000 2.06 1.37 2.75 0.000 1.61 1.28 2.03 0.000 
  R²=0.2014 R²=0.0544 R²=0.0823 Pseudo R²=0.0631 
¹Model adjusted for BP measures and SES at baseline, alcohol intake, height and age at 18yrs, sex,  growth (SGA, relative weight gain in infancy  and mi-childhood)  
²Model adjusted for BP measures and SES at baseline, alcohol intake at 18yrs,  growth (SGA, relative weight gain in infancy  and mi-childhood)  
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 Sex differences association between SES change and systolic blood pressure (SBP) at 18 years of age Appendix 6
Covariates SBP at 18 years of age 
SES change BOYS(n=332) GIRLS(n=324) 
Low-low(ref) β 95%CI p value β 95%CI p value 
Low-medium -3.86 -7.4 -0.33 0.032 3.4 -0.89 7.69 0.120 
Low-high -9.11 -14.59 -3.62 0.001 -0.22 -6.15 5.71 0.940 
Medium-low -1.25 -5.88 3.37 0.594 1.4 -3.86 6.67 0.600 
Medium-Medium -4.03 -8.93 0.86 0.106 0.02 -6 6.05 0.990 
Medium-high -1.58 -6.5 3.33 0.527 3.1 -3.74 9.95 0.370 
High-low -6.05 -12.21 0.11 0.054 -1.43 -9.17 6.3 0.720 
High-Medium -3.4 -9.5 2.7 0.273 1.05 -6.49 8.58 0.780 
High-high -3.8 -10.07 2.46 0.233 -1.79 -10.19 6.61 0.680 
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Current participant age, yrs 4.01 1.15 6.87 0.006 1 -2.13 4.14 0.530 
Current participant height, cm 0.17 0.01 0.33 0.038 0.02 -0.17 0.21 0.840 
Baseline BP  at 5 yrs 0.2 0.12 0.28 0 0.06 -0.03 0.15 0.210 
Household SES in infancy  0.08 -1.38 1.55 0.91 0.76 -1.23 2.75 0.450 
Current alcohol intake 2.85 -0.02 5.72 0.051 1.41 -2.62 5.44 0.490 
Small for gestational age(SGA) 1.1 0.07 2.13 0.036 1.32 0 2.65 0.050 
Relative weight gain (0-2years) 0.59 -0.4 1.58 0.24 0.05 -0.98 1.09 0.920 
Relative weight gain (2-4years) 4.1 3.03 5.17 0 2.39 1.23 3.55 0.000 
Relative weight gain (4-18years) 1.48 -0.61 3.57 0.166 0.44 -1.88 2.75 0.710 
  R²=0.2921    R²=0.0970  
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 Bayesian information criteria for different number of classes to identify the Appendix 7
best model fit using group based trajectory modeling· 
SBP trajectory group membership  
class number -BIC Posterior probabilities (%) Class proportions (%) 
2 15320.94 0.82 0.87    66.6 33.4    
3 15263.21 0.83 0.71 0.82   28.2 55.3 16.4   
4 15245.94 0.81 0.71 0.77 0.82  25.6 54.5 3.3 16.6  
5 15227.72 0.80 0.70 0.81 0.81 0.82 23.5 53.7 3.4 17.8 1.6 
DBP trajectory group membership  
2 14314.34 0.85 0.83    72.1 27.9    
3 14278.86 0.83 0.70 0.87   52.7 43.3 4.0   
4 14257.14 0.77 0.82 0.72 100.00  21.4 18.1 59.6 0.8  
5 14249.51 0.80 0.80 0.68 0.75 0.99 4.2 6.0 50.4 38.7 0.8 
B:GIRLS 
SBP trajectory group membership  
class number BIC Posterior probabilities Class proportions 
2 16094.31 0.81 0.86       62.8 37.2       
3 16029.43 0.83 0.71 0.82     33.2 53.2 13.6     
4 16001.34 0.84 0.67 0.78 0.79   30.5 50.2 10.6 8.7   
5 15986.83 0.84 0.76 0.66 0.80 0.88 27.9 11.9 49.4 10.1 0.7 
DBP trajectory group membership  
2 15196.43 0.78 0.85    58.2 47.8    
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3 15133.37 0.71 0.86 0.93   49.3 48.9 1.9   
4 15126.8 0.70 0.79 0.73 0.90  48.1 39.6 10.4 1.9  
5 15105.95 0.82 0.80 0.63 100.00 0.71 32.8 13.0 46.9 0.2 7.0 
*Model fit criterion included a BIC, posterior probabilities and class proportions starting from a 
two-class to a seven-class model 
†the graphical presentation was also taken into account for model fit criteria (see figure1 and 2) 
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 Characteristics of black children enrolled in Birth to Twenty cohort (BT20) Appendix 8
and the analytical sample 
Characteristics Analytical (n=1937) Excluded(n=631)  Test statistic 
Sex: n (%)    
Male 932(48·1) 314(49·8) ϰ²=0·5167; p=0·472 
Female 1005(51·9) 317(50·2)  
Gestational age (weeks) 37·9(1·8) 38·0(1·9) 0·3328 
Birth weight (g) 3070·7(0·5) 3094·9(0·5) 0·2951 
Participant weight  at 2 years 11·4(1·4) 11·7(1·2) 0·0132 
Participant weight  at 5 years 18·2(2·1) 18·1(1·5) 0·9783 
Participant height at 2 years 83·1(3·3) 82·8(4·0) 0·3646 
Participant height at 5years 107·5(4·5) 106·4(2·9) 0·1267 
SES in infancy (household physical assets) 2(2) 3(2) 0·0000 
Maternal age(years) 25·8(6·2) 26·1(5·9) 0·1843 
Maternal parity 2(1) 2(1) 0·0545 
*Comparison between the analytical and enrolled samples were conducted using a t-test for continuous variables and the chi square test for sex 
differences 
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 Association of age terms and height between 5 and 18 years, and BP Appendix 9
trajectories in boys (A) and girls (B): [est(SE), p value]· 
A: BOYS 
BP trajectory membership SBP DBP 
   estimate  SE P value Estimate SE P value 
Lower  Intercept 54·96657 8·4521 0·0000 13·19449 4·8031 0·0060 
 age 2·76482 2·06446 0·1806 9·2305 1·26746 0·0000 
 age² –0·69844 0·18491 0·0002 –0·99558 0·11292 0·0000 
 age³ 0·02714 0·00512 0·0000 0·02978 0·00313 0·0000 
 height 0·52719 0·03988 0·0000 0·21631 0·02545 0·0000 
  
Middle Intercept 61·75927 9·3720 0·0000 2·48097 7·14448 0·7284 
 age 0·20566 1·73997 0·9059 13·5148 1·79941 0·0000 
 age² –0·47453 0·1554 0·0023 –1·27737 0·16354 0·0000 
 age³ 0·02108 0·00433 0·0000 0·03612 0·00457 0·0000 
 height 0·47579 0·03402 0·0000 0·19771 0·03542 0·0000 
   
Upper Intercept 147·7969 6·4370 0·0000 128·2765 31·42626 0·0000 
 age –27·0923 5·87834 0·0000 –27·5346 8·72308 0·0016 
 age² 1·80292 0·53049 0·0007 2·52555 0·81421 0·0019 
 age³ –0·04032 0·0149 0·0068 –0·0709 0·02319 0·0022 
 height 0·74727 0·11617 0·0000 0·28869 0·15986 0·0710 
         
B: GIRLS 
 BP trajectory membership SBP DBP 
  Estimate  SE P value Estimate SE P value 
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Lower  Intercept 57·5533 6·87806 0·0000 16·21327 5·54732 0·0035 
 age 7·03695 1·75165 0·0001 10·87849 1·36305 0·0000 
 age² –0·97357 0·15972 0·0000 –1·07238 0·12508 0·0000 
 age³ 0·03399 0·00453 0·0000 0·03151 0·00355 0·0000 
 height 0·27137 0·03922 0·0000 0·12002 0·03241 0·0002 
  
Middle Intercept 102·3708 7·39317 0·0000 26·8031 5·57144 0·0000 
 age –0·85209 1·80256 0·6364 9·91387 1·40324 0·0000 
 age² –0·23534 0·16528 0·1545 –0·88626 0·12771 0·0000 
 age³ 0·0133 0·0047 0·0046 0·02489 0·00361 0·0000 
 height 0·19018 0·04367 0·0000 0·08041 0·03052 0·0085 
  
Upper Intercept 90·07066 18·16137 0·0000 43·50199 29·40977 0·1392 
 age 14·54482 4·65254 0·0018 15·92225 7·38911 0·0312 
 age² –1·02141 0·41636 0·0142 –1·11563 0·67744 0·0997 
 age³ 0·02562 0·01174 0·0291 0·0292 0·01919 0·1283 
 height –0·25451 0·10182 0·0125 –0·26558 0·15897 0·0949 
*The level (intercept) and change (age-linear, age²-quadratic and age³-cubic terms) of blood pressure, standard errors and level of significance of 
the three height-adjusted blood pressure trajectories 
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  Association between BP status(>95th percentile for age, sex and height) at age Appendix 10
5 years and being in the middle and upper BP compared to the lower trajectories in urban 
black South African children aged 5-18 years* 
 
*The relative risk ratios and the 95% confidence intervals of being in the middle or upper trajectory compared to the lower trajectory given blood 
pressure status at age 5(reference: 0:  ≤95th percentile;1: >95th percentile for age, height and sex) 
 
 
 
 SBP trajectory DBP trajectory 
 RRR(95%CI) P value RRR(95%CI) P value 
A. BOYS     
Lower trajectory group(ref)     
Middle trajectory group 3.85(2.25-6.59) 0.000 3.09(1.94-4.92) 0.000 
Upper trajectory group 21.80(8.72-54.50) 0.000 14.15(3.40-58.83) 0.000 
B.GIRLS     
Lower trajectory group(ref)     
Middle trajectory group 5.69(3.41-9.52) 0.000 4.62(2.92-7.34) 0.000 
Upper trajectory group 7.05(3.03-16.38) 0.000 9.27(2.66-32.30) 0.000 
 
